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Aging-Delaying Plant Extracts Cause Age-Related Changes in Cellular and Organellar 
Lipidomes of the Chronologically Aging Yeast Saccharomyces Cerevisiae  
 
Veronika Svistkova, M.Sc. 
 
The yeast Saccharomyces cerevisiae has been successfully used to identify genes, signaling 
pathways and chemical compounds that delay cellular and organismal aging in evolutionarily 
distant eukaryotes. These findings provided evidence that the mechanisms of biological aging on 
a cellular level have been conserved in the course of evolution. Recent studies revealed 6 plant 
extracts that delay chronological aging in S. cerevisiae. All these plant extracts are more efficient 
aging-delaying interventions than any of the currently known longevity-extending chemicals. As 
a first step towards uncovering molecular mechanisms through which the 6 plant extracts delay 
yeast chronological aging, I used quantitative mass spectrometry to compare the concentrations 
of different classes of lipids in cells and cellular organelles of chronologically aging yeast 
exposed to each of these extracts or remained untreated. I demonstrate that each of the 6 aging-
delaying plant extracts causes age-related changes in cellular and organellar lipidomes of 
chronologically aging yeast. My findings suggest that each of these extracts differently alters the 
relative rates of phosphatidic acid flow into the biosynthetic pathways for triacylglycerols in the 
endoplasmic reticulum, glycerol phospholipids in the endoplasmic reticulum and mitochondria, 
and cardiolipin in mitochondria. Such re-wiring of phosphatidic acid conversion into 
triacylglycerols, glycerol phospholipids and cardiolipin delays aging by mechanisms that remain 
to be established. My study provides important knowledge on which aspects of lipid metabolism 
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1.1 The yeast Saccharomyces cerevisiae is a beneficial model for uncovering 
mechanisms of cellular aging in multicellular eukaryotic organisms 
Aging affects all biological organisms, from simple eukaryotes to human beings. 
The budding yeast Saccharomyces cerevisiae is a simple, unicellular eukaryote that has 
been used as a model organism for studying aging. [1] It has a short lifespan, its genome 
has already been sequenced, and it can be easily cultured under laboratory conditions. 
These benefits make S. cerevisiae an ideal organism to discover novel genes or signaling 
pathways that regulate aging. [1] Studies confirmed that the mechanisms that control 
cellular aging are maintained in eukaryotes across phyla. [1] S. cerevisiae has helped in 
the identification of many genes involved in regulating aging. [2, 3] It is also commonly 
used to screen extensive libraries of numerous chemical compounds for those that can 
delay aging. [2] A few anti-aging drugs have already been found using yeast. Those drugs 
include resveratrol, rapamycin and spermidine. [4] Resveratrol is a chemical compound 
initially found in red wine; it has been shown to extend the lifespan of yeast, nematodes, 
flies and short-OLYHGILVK>@+RZHYHUVWXGLHVLQPLFHGLGQ¶WVKRZDQLncrease in 
lifespan. [4] Resveratrol was found to activate sirtuins, a family of NAD+-dependent 
deacetylases. [4] Activation of sirtuins was already found to increase the lifespan of 
yeast, nematodes and flies. [4] Resveratrol is currently being clinically tested as a 
treatment for type 2 diabetes and metabolic syndrome. [4, 6] Another drug whose aging-
delaying effects have been initially discovered in yeast is rapamycin, also called 
sirolimus. [4] It is a chemical with antifungal properties and is a macrocyclic lactone 




with other drugs as an immunosuppressant in renal transplantation and it was found to 
reduce the level of malignancies in renal-transplant recipients. [9] Recent studies have 
VKRZQWKDWUDSDP\FLQSUHYHQWVGHILFLWVLQPHPRU\LQPRXVHPRGHOVRI$O]KHLPHU¶V
disease. [7] Spermidine, another molecule with anti-aging properties, can interact with 
RNA, DNA, and lipids due to the presence of cations in its structure. [10] Research has 
shown that when yeast, nematodes, fruit flies and human peripheral blood mononuclear 
cells where exposed to this chemical agent, their lifespan increased. [10] Spermidine can 
also alter the lipid metabolism in the fruit fly Drosophila melanogaster. [10] Resveratrol, 
rapamycin and spermidine are only few examples of compounds that have been 
discovered to be aging-delaying compounds in studies of the yeast S. cerevisiae. Aging-
delaying compounds discovered in studies of yeast have also been also used for the 
discovery of several key protein components of the anti-aging and pro-aging pathways; 
these key protein components are sirtuins and the TOR (target of rapamycin) protein 
kinases, respectively. [4] The abilities of both these proteins to define the pace of aging 
have been conserved in the course of evolution. [4] 
 
1.2 Two different modes of yeast aging  
When referring to the aging of yeast, some keys concepts need to be defined. Two 
types of aging are known in yeast; they are called replicative and chronological aging 
(Figure 1.1). [3] The ways for monitoring these two types of aging differ. [3] Some 
proteins are master regulators of only the replicative mode of aging, others regulate only 
the chronological mode of aging, whereas some proteins play essential roles in regulating 






Figure 1.1 Two different modes of yeast aging. Replicative aging is monitored by 
assessing the number of mitotic divisions a mother cell can undergo before becoming 
senescent. Chronological aging is monitored by assessing a number of days a yeast cell 
remains viable after entering stationary phase of growth that is after becoming senescent. 
[11] 
 
Yeast replicative aging occurs because S. cerevisiae proliferates by budding of a small 
daughter cell from a large mother cell. [3] A mother yeast cell can divide a limited 
number of time, and the higher this number is, the higher the replicative lifespan (RLS) 
of this particular yeast cell. A single yeast cell can form not more than 20 to 25 cells, and 
then becomes unable to replicate by budding. [3] The cell that gives rise to the new cells 
LVUHIHUUHGWRDV³PRWKHU´FHOODQGWKHQHZFHOOVDUHcalled ³GDXJKWHU´FHOOVYeast RLS 
can be used as a model for mitotically active mammalian cells. [4] Measuring RLS in the 
laboratory involves a standard tetrad dissection microscope with a micromanipulator that 
can remove the daughter cells. This would allow to keep track of how many times a cell 
undergoes budding. [3] Other methods of monitoring yeast RLS have recently emerged. 
For example, the mother cell can be coated with biotin, and the daughter cells that 




can be counted. [3] Research has shown that the capacity of a yeast cell to replicate a 
finite number of times depends on various cellular processes. [2] These processes take 
place in different cellular locations, occur at different stages of the RLS (i.e. at the early, 
intermediate or late stage of the RLS), and contribute to the accumulation of so-called 
aging factors. [2] Before taking a look into the cellular processes that define yeast RLS, 
the different stages of replicative aging need to be outlined. The early stage of the RLS 
lasts from cell birth to the completion of first 10 cell divisions, the intermediate stage 
refers to the period of time between cell divisions 10 and 20, and the late-age stage 
involves the period of time between cell division 20 and cell death. [2] One of the cellular 
processes that drives yeast replicative aging is a gradual decline of vacuolar functionality. 
Vacuoles in yeast play the role of lysosomes in mammals. [12] Vacuoles undergo an 
increase in pHduring the early stage of the RLS, increase in size during the intermediate 
stage, and further enlargement during the late stage. [2] Another aging factor in 
replicating yeast cells is the age-related accumulation of protein aggregates, which 
suggests a gradual impairment of cellular proteostasis in replicatively aging yeast. [2] 
From the early stage to the late stage of the RLS, there is a gradual increase in the 
abundancies of oxidatively damaged and aggregated proteins. [2] The build-up of such 
aggregates is one of the hallmarks of replicative aging in yeast. [2] Several factors related 
to mitochondrial functionality can also serve as hallmark events of yeast replicative 
aging. [2] These factors become noticeable during the intermediate and late stages of the 
RLS. [2] During the intermediate stage, mitochondrial membrane potential is decreased 
and reactive oxygen species (ROS) accumulate; both these processes continue during the 




aggregates and lose their DNA. [2] Some changes in replicatively aging yeast are known 
to affect the nucleus. During the intermediate stage of replicative aging, histones in the 
subtelomeric regions of the chromatin undergoacetylation and dissociate, thereby 
allowing transcription of these chromatin regions. [2] During this stage, there is also a 
significant increase in the number of extrachromosomal rDNA circles (ERCs) within the 
nucleus; such increase in the abundance of ERCs marks a transition from the intermediate 
stage to the late stage of the RLS. [2] Recent findings indicate that the rise in the number 
of ERCs is one of the key indicators of aging. [2] Mutants that exhibit an accelerated 
accumulation of ERCs (as compared to a wild-type strain) age prematurely and have 
shortened replicative lifespan. [13] Other type of organelles undergoing characteristic 
changes during yeast replicative aging are peroxisomes. [3] These organelles 
accommodate such important metabolic processes as fatty acid oxidation and 
decomposition of hydrogen peroxide, a ROS molecule. [3] Peroxisomes also contribute 
to the maintenance of ROS homeostasis in the cell by housing ROS-producing oxidases. 
[14] Moreover, protein import into peroxisomes is known to gradual decrease during 
replicative aging in yeast. [2]  
The RLS-defining cellular processes mentioned above are regulated by 2 groups 
of mechanisms that can slow down replicative aging by operating within a mother cell. 
The first group of such mechanisms allows to prevent or decelerate the buildup of 
different aging factors in the mother cell. [3] An example of a pathway that belongs to 
this group of aging-delaying mechanisms is the unfolded protein response (UPR) 
signaling. [3] As mentioned earlier in the text, aggregates of proteins becoming more 




the UPR signaling pathway is triggered in the endoplasmic reticulum (ER); this initiates a 
cascade of events that ultimately activate transcription of many UPR target genes, 
including protein chaperones confined to the ER. [15, 16] Another example of a pathway 
from the first group of replicative aging-delaying mechanisms is a specialized form of 
autophagy. This form of autophagy is activated in response to accumulation of 
oxidatively damaged lipids within the mother cell. It involves a translocation of a lipase 
from the ER to the vacuoles and subsequent lipolytic degradation of oxidatively damaged 
membranes within autophagosomes. [3, 17] This ensures degradation of dysfunctional 
and/or damaged organelles, as well as aggregates of organelles and proteins. [3, 17]  
The second group of mechanisms that can slow down replicative aging by 
operating within a mother cell is the one which prevents a transmission of accumulated 
aging factors from the mother cell to the daughter cell. This ensures that the daughter cell 
remains replicatively ³\RXQJ´DQGGRHVQRWLQKHULWthe aging factors accumulated in the 
UHSOLFDWLYHO\³ROG´PRWKHUFHOO. [3] An example of such mechanisms is the association of 
protein aggregates with the actin cytoskeleton. Such association prevents a transfer of the 
protein aggregates from the mother cell to the daughter cell during budding. [2] Another 
example for the second group of aging-delaying mechanisms operating within a mother 
cell is a mechanism which prevents a transfer of dysfunctional mitochondria from the 
mother cell to the daughter bud. [18] Such transfer of mitochondria is driven by motor 
proteins that walk on the bundles of actin filaments. Mitochondria that are functional are 






Figure 1.2 An age-related accumulation a distinct set of aging factors promotes both 
replicative and chronological aging in yeast. An age-related accumulation of damaged 
mitochondria and oxidized proteins causes both replicative and chronological aging in 
yeast. Extrachromosomal rDNA circles gradually accumulate in the mother cell, thereby 
promoting its replicative aging. [4] 
 
The chronological lifespan (CLS) of yeast differs from yeast RLS by definition 
and by the way it is measured under laboratory conditions. It refers to the ability of non-
dividing (quiescent and senescent) yeast cells to remain viable for a certain time period 
during stationary growth phase. [3] The longer a cell remains viable, the longer the CLS 
of such cell. [3] When yeast cells are cultured in a liquid medium initially containing 
glucose as a sole carbon source, they entirely consume glucose after approximately 24 
hours and reach so-called post diauxic growth phase. During this phase, yeast cells 





After the end of the post diauxic phase, yeast cells enter stationary growth phase. In 
stationary phase, the majority of cells exits the cell cycle and remains in a viable yet non-
dividing state. [3] This non-dividing state of yeast cells undergoing chronological aging 
is being used as a model to study aging of non-diving cells of higher eukaryotic 
organisms. [3] Moreover, this non-dividing state of chronologically aging yeast cells is 
also considered as a model for organismal aging of higher eukaryotes. [1] The common 
method to measure CLS is a so-called clonogenic assay. [1] In this assay, the viability of 
a yeast cell is tested by plating this cell on the surface of a solid nutrient-rich medium. [1] 
If a cell is able to form a colony, it is considered to be viable because it is capable to 
reproduce by budding. [1] In the clonogenic assay of yeast CLS, the percentage of viable 
cells in the liquid medium is calculated at different consecutive time points. [1]  
Certain cellular processes and a distinct set of proteins influence the length of 
yeast CLS. [1] Some of these processes and proteins have been shown to define yeast 
CLS by acting prior to the entry into the non-dividing state, whereas others do so only 
after a yeast cell enters this non-proliferative state. [1] Thus, the process of chronological 
aging in yeast can be divided into two equally important consecutive phases. The initial 
SKDVHRI\HDVWFKURQRORJLFDODJLQJRFFXUVLQFKURQRORJLFDOO\³young´FHOOVZKHUHDVWKH
VXEVHTXHQWSKDVHWDNHVSODFHLQFKURQRORJLFDOO\³old´ cells. [1]  
Cellular processes that define the progression through the two consecutive phases 
of yeast chronological aging and define yeast CLS are subjected to complex 
spatiotemporal regulation. [1] These cellular processes are involved in metabolism, 
growth, proliferation, macromolecular homeostasis and stress resistance. [1] One of the 




The intracellular concentrations of this disaccharide in both FKURQRORJLFDOO\³\RXQJ´DQG
³ROG´yeast cells play an important role in defining longevity of chronologically aging 
yeast. [1]  
It has been found WKDWLQFKURQRORJLFDOO\³\RXQJ´yeast cells, trehalose can bind 
to newly synthesized proteins. Such binding to trehalose stabilizes these newly 
synthesized proteins by preventing their improper folding and aggregation through the 
protection of exposed hydrophobic parts of misfolded proteins, as well as by limiting 
their oxidation through the shielding of oxidation-prone protein domains. [1] In 
FKURQRORJLFDOO\³ROG´yeast cells, the effect of trehalose on yeast CLS is quite different. 
In fact, LIWKHFRQFHQWUDWLRQRIWUHKDORVHLQWKLV³ROG´FHOOVH[FHHGVDWKUHVKROG\HDVW&/6
is shortened. [1] 7KLVLVEHFDXVHLQFKURQRORJLFDOO\³ROG´\HDVWFHlls, trehalose binding to 
hydrophobic regions of misfolded proteins impairs their proper folding by competing 
with molecular chaperones that are needed for such folding. [1] These findings imply that 
the intracellular concentration of trehalose can define yeast CLS by differently 
LQIOXHQFLQJSURWHLQKRPHRVWDVLVLQFKURQRORJLFDOO\³\RXQJ´DQG³ROG´FHOOV. [1]  
As mentioned earlier, protein import into peroxisomes gradually deteriorates in 
yeast cells that age replicatively. [2] Such age-related deterioration of peroxisomal 
protein import has been also observed in chronologically aging yeast. In chronologically 
³young´ yeast cells, protein import into peroxisomes is highly efficient. [1] Proteins that 
are efficiently imported into the peroxisome in these chronologically ³young´ yeast 
include enzymes needed to break down hydrogen peroxide and other ROS, enzymes 
involved in the ȕ-oxidation of fatty acids, and enzymes needed to synthesize 




the proteins called Pex5p and Pex7p. [1] It has been shown that when the efficiency of 
peroxisomal import of these proteins decreases below a certain threshold, a pro-aging 
cellular pattern is established. [1] Indeed, in FKURQRORJLFDOO\³\RXQJ´yeast cells the 
efficiency of such peroxisomal protein import exceeds the threshold level, whereas and in 
FKURQRORJLFDOO\³ROG´yeast cells such efficiency drops below the threshold. [1] Recent 
evidence supports the notion that the establishment of the pro-aging pattern in 
FKURQRORJLFDOO\³ROG´yeast cells with reduced peroxisomal protein import is due to the 
following equally important processes: 1) an elevation of intracellular concentrations of 
hydrogen peroxide and other ROS, which increases the extent of oxidative damage to 
macromolecules; 2) a reduction in peroxisomal fatty acids oxidation, which promotes a 
buildup of free fatty acids known to trigger a so-called liponecrotic form of programmed 
cell death; and 3) a decrease in the production of TCA cycle intermediates, which triggers 
a cascade of events involving a reduced efficiency of the electron transport chain in 
mitochondria, mitochondrial fragmentation, and the efflux of cytochrome c (all these 
factors are known to elicit an apoptotic form of programmed cell death). [1] 
As a result of the above findings, yeast CLS is viewed as a progression through 
VHYHUDOFRQVHFXWLYH³checkpoints´>@7KHHIILFLHQF\RISURJUHVVLRQWKURXJKHDFKRI
WKHVH³checkpoints´GHILQHVORQJHYLW\RIFKURQRORJLFDOO\DJLQJ\HDVWDQGLQYROYHVD
distinct set of cellular processes. [1, 2] Several of these checkpoints are known to occur 
LQFKURQRORJLFDOO\³\RXQJ´FHOOV progressing through logarithmic, diauxic and post 
diauxic phases of growth. [1] The rates and efficiencies of progression of longevity-
defining cellular processes through each of these checkpoints define longevity of 




decrease below a threshold, molecular damage begins to accumulate. [2] Such age-related 
accumulation of damage to cellular molecules accelerates yeast chronological aging. [2]  
Moreover, yeast CLS is also known to be influenced by the acidity of the medium 
in which yeast cells are cultured. [4] Indeed, yeast cells that underwent a diauxic 
transition from logarithmic phase to stationary phase are metabolizing ethanol as the 
secondary energy source. [4] This favors the release of acetic acids and other organic 
acids in the medium and, thus, promoting an acidification of this medium. [4] Acetic acid 
can enter the cell by simple diffusion and lower the intracellular pH. [19] This 
acidification has been shown to hinder vesicle trafficking and affect cellular metabolism. 
[19] Importantly, increasing pH of the medium by the use of certain buffers can increase 
yeast CLS. [4]  
Taken together, both RLS and CLS are important for understanding mechanisms 
of the aging process in yeast. Yeast RLS mimics aging of mitotically active human cells, 
whereas yeast CLS is a benefitial model for studying aging on non-dividing human cells. 
[4] Until recently, the two types of yeast aging have been studied separately from each 
other because they were considered to be independent processes. [4] However, recent 
studies have provided evidence that RLS and CLS are partially overlapping and mutually 
dependent processes in yeast. [4] Indeed, a caloric restriction diet has been shown to 
extend both these types of lifespan in yeast. [2] Furthermore, an attenuation of the pro-
aging TOR/Sch9 pathway (see below) extends both RLS and CLS in yeast. [2] It needs to 
be emphasized that CLS and RLS do not fully overlap in yeast; indeed, some single-





1.3 A network of integrated signaling pathways and protein kinases defines the 
rate of yeast chronological aging  
Aging is a complex process, which is regulated by a distinct set of master 
regulator proteins integrated into a network of overlapping nutrient-sensing pathways of 
signal transduction. [20]  
One of these master regulator proteins is a nutrient-sensing serine/threonine 
protein kinase, TOR (target of rapamycin). Yeast, algae, slime mold, plants, worms, flies 
and mammals all possess a TOR gene. [20] Two TOR complexes are presently known, 
TORC1 (referred to as mTORC1 for mammals) and TORC2 (referred as mTORC2 in 
mammals). [21] While TORC2 is known mainly for its essential role in controlling the 
actin cytoskeleton dynamics, TORC1 has been linked to many cellular processes that 
impact cellular and organismal aging in evolutionarily distant eukaryotes. [21] TORC1 
regulates translation, transcription, ribosome formation, nutrient transport across 
membranes and autophagy. [11, 21] The TORC1 pathway is considered to be a pro-aging 
pathway since mutants with reduced TORC1 activity exhibit an increase in both RLS and 
CLS not only in yeast but also in such evolutionarily distant eukaryotic organisms as 
worms, fruit flies and mice. [11] In order to regulate translation, it is believed that 
TORC1 interacts with the translation initiation factor eIF4E. [22] The exact mechanism 
of translational regulation by TORC1 remains to be defined. [22] The TORC1 pathway is 
able to coordinate the formation of new ribosomes by favouring the transcription of genes 
that encode mRNAs for ribosomal proteins, rRNAs and tRNAs. [11, 22] TORC1 can also 
activate the import of amino acids across the plasma membrane into the cell. [11] Amino 




help of various permeases. [22] TORC1-driven signaling is known to activate amino acid 
import by stimulating activities of amino acid permeases. [22] Indeed, the inhibition of 
the TORC1 pathway by rapamycin has been shown to decrease the import of exogenous 
amino acids across the plasma membrane. [22] Inhibition of TORC1 by rapamycin also 
stimulates autophagy, thus suggesting that TORC1 inhibits autophagic degradation of 
cellular organelles and macromolecules. [22]  
TORC1 signaling is known to inhibit transcription driven by such transcription 
factors as Msn2, Msn4 (both of which activate transcription of stress-response genes 
under caloric restriction conditions) and bHLH/Zip (which induces expression of genes 
encoding enzymes involved in synthesis of some metabolic intermediates). [22]  
TORC1 can respond to changes in nutrient availability to yeast cells by 
phosphorylating and activating the nutrient-sensing protein kinases Sch9 (an ortholog of 
S6K in mammals) and protein kinase A (PKA). [11, 23] It needs to be emphasized that, 
similarly to attenuation of TORC1, a mutational impairment of Sch9 or a decreased 
activity of PKA have been shown to extend both RLS and CLS in yeast. [23] TORC1, 
Sch9 and PKA are considered to be nutrient-responsive kinases that promote aging. [23] 
Their combined action is believed to cause a global suppression of the ability of yeast to 
respond to various age-related stresses.  TORC1, Sch9 and PKA suppress stress response 
by preventing the import of Msn2/4 heterodimers into the nucleus, thereby attenuating 





Figure 1.3 The ability of yeast to respond to the availability of exogenous 
nutrients define CLS. Sch9, Tor1 and Ras respond to nutrients availability by 
preventing the Rim15-dependent activation of oxidative stress response. This elicits an 
increase in O2- concentration, which in turn causes oxidative macromolecular damage and 
accelerates yeast chronological aging. [24] 
 
The network of nutrient-sensing signaling pathways and protein kinases shown in 
Figure 1.3 has been shown to coordinate an abundance of longevity-defining cellular 
processes in chronologically aging yeast. These processes include stress response, protein 
synthesis in the cytosol and mitochondria, maintenance of nuclear and mitochondrial 
genomes, autophagy, mitochondrial respiration, peroxisome biogenesis, gluconeogenesis, 
lipid metabolism, glyoxylate cycle, glycogen synthesis and degradation, and the synthesis 





1.4 Metabolism of different lipid classes in yeast cells    
Lipids in yeast cells are known for their essential roles in the assembly and fusion 
of membrane bilayers, the stabilization and vesicular trafficking of membrane proteins, 
signal transduction, apoptosis, and energy storage. [25, 26, 27] Because most of the 
aspects of lipid metabolism and function have been conserved in the course of evolution, 
the budding yeast S. cerevisiae have been successfully used as an advantageous model 
organism for uncovering mechanisms underlying all these vital processes in cells of 
multicellular eukaryotic organisms. [25]            
The metabolic pathways for the biosynthesis, degradation and storage of different 
classes of lipids have been extensively studied in yeast. [25, 26, 27] One of these lipid 
classes is the class of phospholipids, the most abundant lipid constituents of organellar 
and plasma membranes in yeast. They include phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylinositol (PI) and phosphatidylserine (PS). 
Of note, membrane bilayers of different organelles in yeast cells differ from each other in 
the relative levels of PC, PE, PI and PS; it is believed that such difference in phospholipid 
composition is one of the key reason for the differences in functions of these organelles. 
[25, 26, 27] Moreover, some lipid species of the phospholipid class can be found only in 
the inner and outer mitochondrial membranes; in yeast mitochondria, these lipid species 
are phosphatidylglycerol (PG) and cardiolipin (CL). [25, 26, 27]               
Two classes of lipids in yeast cells, namely triacylglycerols (TAG) and steryl 
esters (SE), belong to so-called neutral lipids. [25, 26, 27] TAG and SE are deposited 




phospholipids and a limited number of proteins. [26] In addition to playing essential roles 
as a source of energy and precursors for membrane lipid synthesis, TAG and SE serve as 
a chemical form for the detoxification of such lipid classes as free fatty acids (FFA) and 
sterols. [26] 
  Although the synthesis of phospholipids and neutral lipids in yeast is confined to 
various organelles (including the ER, mitochondria and LD), a phospholipid called 
phosphatidic acid (PA) serves as a common precursor molecule for all of these lipid 
classes. [25, 26, 27] All phospholipids are synthesized via theCDP-DAG (CDP-
diacylglycerol) branch of PA conversion, whereas TAG and SE are formed through the 
DAG (diacylglycerol) of PA conversion. (Figure 1.4) [25, 26, 27]  CDP-DAG is a 
liponucleotide intermediate which serves as a precursor for the synthesis of PI and PS in 
the ER. (Figure 1.4) [25, 26, 27] Further metabolic conversion of PS occurs in 
mitochondria and results in the formation of PE. (Figure 1.4) [25, 26, 27] The subsequent 
conversion of PE to PC occurs in the ER. (Figure 1.4) [25, 26, 27]CDP-DAG also serves 
as a precursor in the synthesis of PG and then CL in the inner mitochondrial membrane. 
(Figure 1.4) [25, 26, 27] Thus, the biosynthesis of phospholipids in yeast is a highly 
organized process which involves a synthesis of various lipid intermediates in the ER and 
mitochondria and a bidirectional transport of these intermediates between these 
organelles. (Figure 1.4) [25, 26, 27] Two phospholipids, PC and PE, can also be formed 
from DAG via the Kennedy pathway, which requires exogenous choline and 





Figure 1.4 Pathways for lipid synthesis, interorganellar transport and 
degradation in a yeast cell. PA is a precursor for the synthesis of both phospholipids and 
neutral lipids. Phospholipids PC, PE, PI, PS, PG and CL are synthesized via the CDP-
DAG branch of PA conversion in the ER and mitochondria. An alternative route for the 
synthesis of PC and PE is the Kennedy pathway, which uses DAG as a precursor and 
requires exogenous choline and ethanolamine. Neutral lipids TAG and SE are first 
synthesized via the DAG branch of PA conversion in the ER, and are then deposited in 
the LD. Both neutral lipids can be used as a source for replenishing the pools of PA, 
DAG and FFA for lipid synthesis or degradation. [25]  
 
TAG and SE are synthesized via theDAG (diacylglycerol) of PA conversion in 
the ER of yeast cells. (Figure 1.4) [25, 26, 27] These two neutral lipids are then 
deposited in the LD which forms by budding from the ER. (Figure 1.4) [25, 26, 27] TAG 
and SE can be used as an abundant source for the replenishment of the pools of PA, DAG 
and FFA, which can be then used for lipid synthesis or degradation. (Figure 1.4) [25, 26, 
27] 





1.5 Some dietary and pharmacological interventions delay yeast chronological 
aging by altering lipid metabolism 
Various changes in the environmental conditions, including changes in nutrients 
availability, can dramatically change the cellular and organellar lipidomes of yeast cells 
by re-wiring the network of overlapping metabolic pathways schematically depicted in 
Figure 1.4. [28] Some of these changes can delay chronological aging in yeast, as 
outlined below.  
An aging-delaying dietary intervention which has been shown to remodel lipid 
metabolism is so-called caloric restriction (CR). [30] CR is a robust longevity-extending 
dietary intervention known to delay aging not only in yeast but also in worms, fruit flies 
and mice. [30] In chronologically aging yeast, CR can be administered by lowering the 
final concentration of glucose in growth medium from 2% (non-CR conditions) to 0.2%. 
[30] It has been shown that under non-CR conditions chronologically aging yeast 
accumulates ethanol, the major product of glucose fermentation. [30, 31] Ethanol 
suppresses peroxisomal oxidation of FFA, which under non-CR conditions are formed 
due to the lipolytic degradation of TAG deposited in the LDs. [30, 31] This causes an 
accumulation of FFA in the LDs, thus enabling FFA to initiate several negative feedback 
loops that elicit the build-up of DAG and FFA in the ER. [31] The excessive 
accumulation of these two lipid classes accelerates yeast chronological aging by 
triggering an age-related form of programmed cell death called liponecrosis. [29, 30, 31] 
The CR diet delays chronological aging in yeast by significantly lowering the 
intracellular concentration of ethanol and, thus, by preventing the suppression of FFA 




the ER, thus delaying the onset of liponecrotic cell death and slowing down yeast 
chronological aging. [29, 30, 31]                 
An aging-delaying pharmacological intervention which has been shown to 
remodel lipid metabolism is lithocholic acid (LCA), the most hydrophobic bile acid. [31, 
32] This LCA-driven re-wiring of lipid metabolism in chronologically aging yeast 
involves the following three processes. First, LCA promotes mitochondrial transport of 
acetyl-CoA to limits its availability for the synthesis of FFA in the ER. [31] Second, LCA 
stimulates TAG synthesis from FFA and DAG in the ER. [31] Third, LCA decelerates the 
lipolysis of TAG to FFA and DAG. [31] Because of these three effects of LCA on lipid 
metabolism and transport, LCA causes a decrease in the intracellular concentrations of 
FFA and DAG. This, in turn, delays the onset of liponecrosis which can be triggered by 
these two lipids and slows down chronological aging. [31]           
LCA delays yeast chronological aging also by influencing mitochondrial 
composition, structure and function. This bile acid has been shown to cross the plasma 
membrane and then to be sorted to the inner mitochondrial membrane. [33] The 
accumulation of LCA in the inner mitochondrial membrane causes a characteristic 
remodeling of phospholipid metabolism in and phospholipid transport across this 
membrane. [33] This causes significant changes in the relative concentrations of several 
phospholipids within both inner and outer membranes of mitochondria. Specifically, the 
concentrations of PA, PC, PS and PG are increased, whereas the concentrations of PE 
and CL are decreased. [33] Such global changes in phospholipid concentrations trigger a 
significant enlargement of mitochondria, decrease the number of mitochondria, and 




mitochondrial morphology intensify mitochondrial respiration, increase membrane 
potential and VWLPXODWHPLWRFKRQGULDO$73V\QWKHVLVLQFKURQRORJLFDOO\³ROG´\HDVWFHOOV
thus delaying their aging and increasing their lifespan. [33]       
 
1.6 The objectives of studies described in this thesis 
Research in the Titorenko laboratory is aimed at using S. cerevisiae as a model 
organism to unveil molecular mechanisms of cellular aging in multicellular eukaryotic 
organisms. Recent studies in the laboratory discovered 6 plant extracts that greatly delay 
chronological aging in this yeast. My objective was to make a first step towards 
uncovering molecular mechanisms through which each of these plant extracts delays 
yeast chronological aging. To make such initial step, in studies described here I used 
quantitative mass spectrometry to compare the concentrations of different classes of 
lipids in whole cells and cellular organelles of chronologically aging yeast exposed to 
each of these extracts or remained untreated.  
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2 An aging-delaying plant extract PE21 remodels cellular and organellar 
lipidomes of chronologically aging yeast  
 
2.1 Abstract 
Recently published studies conducted in the Titorenko laboratory have identified 6 plant 
extracts that slow down the chronological mode of aging in S. cerevisiae. All these plant 
extracts are significantly more efficient aging-delaying interventions than any of the 
currently known anti-aging chemicals. One of these plant extracts, called PE21, is the 
most potent aging-delaying pharmacological intervention yet described. Recent 
unpublished findings of the Titorenko laboratory suggest that some aspects of lipid 
metabolism and interorganellar transport may play essential roles in the delay of aging by 
PE21. In studies described in this chapter of my Thesis, I have used mass-spectrometric 
quantitative analysis to compare the concentrations of different classes of lipids in cells 
of chronologically aging yeast exposed to PE21 or remained untreated. My findings 
imply that PE21 alters the relative rates of phosphatidic acid (PA) flow into the synthesis 
of other lipids as follows: 1) it decreases the rate of PA flow into the synthesis of 
triacylglycerols (TAG) in the endoplasmic reticulum (ER); 2) it increases the rate of PA 
flow into the synthesis of glycerol phospholipids in the ER and mitochondria; and 3) it 
decreases the rate of PA flow into the synthesis of cardiolipin (CL) in mitochondria. Such 
re-wiring of PA conversion into TAG, glycerol phospholipids and CL delays aging by a 
mechanism that remains to be established. 
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2.2 Materials and Methods 
 
Yeast strains, media and growth conditions 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATD his3'1 leu2'0 lys2'0 
ura3'0) from Thermo Scientific/Open Biosystems was grown in a synthetic minimal 
YNB medium (0.67% Yeast Nitrogen Base without amino acids) initially containing 2% 
glucose and supplemented with 20 mg/l histidine, 30 mg/l leucine, 30 mg/l lysine and 20 
mg/l uracil. Cells were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer 
IODVNVDWD³IODVNYROXPHPHGLXPYROXPH´UDWLRRIThe stock solution of aging-
delaying plant extract 21 (PE21) in ethanol was made on the day of adding this PE to cell 
cultures. This stock solution was added to growth medium immediately following cell 
inoculation into the medium. The final concentration of PE21 in growth medium was 
0.1%. 
 
Lipid extraction from yeast cells [34] 
Yeast cells were harvested by centrifugation in a Centra CL2 clinical centrifuge at 3,000 
× g for 5 min at room temperature. The cell pellet was resuspended in ice-cold 155 mM 
ammonium bicarbonate (pH 8.0), and the cells were subjected to centrifugation at 16,000 
× g for 1 min at 4oC. The cell pellet was stored at -୲&XQWLOOLSLGH[WUDFWLRQ)RUOLSLG
extraction, the pelleted cells kept at -୲&ZHUHWKDZHGRQLFHEHIRUHEHLQJUHVXVSHQGHG
in 1 mL of ice-cold nanopure water. The volume that contained 5 × 107 cells was 
transferred to a 15-mL high-strength glass screw top centrifuge tube with a Teflon lined 
cap (#0556912; Fisher Scientific). The volume of each sample was topped off to 1 mL 
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with ice-cold nanopure water. To each tube the following was added: 20 μL of the 
internal standard mix prepared in Chromasolv HPLC (>99.9%) chloroform (Sigma-
Aldrich) (Table 2.1), 800 μL of 425-600 μM acid-washed glass beads to break open the 
cells (#G8772; Sigma-Aldrich) and 3 mL of a Chromasolv HPLC (>99.9%) chloroform-
methanol mixture (both from Sigma-Aldrich) at a 17:1 ratio. The samples were then 
YRUWH[HGYLJRURXVO\IRUKDW୲&DQGVXEMHFWHGWRFHQWULIXJDWLRQLQD&HQWUD&/
clinical centrifuge at 3,000 × g for 5 min at room temperature; this centrifugation allowed 
to separate the upper aqueous phase from the lower organic phase, which contained 
nonpolar lipids TAG, PC, PE and PG. The lower organic phase was then transferred to 
another 15-mL high-strength glass screw top centrifuge tube using a glass Pasteur pipette 
with careful attention not to disrupt the glass beads or upper aqueous phase. 1.5 mL of 
chloroform-methanol (2:1) solution was added to the remaining upper aqueous phase to 
allow the separation of polar lipids PA, PS, PI and CL. The samples were again vortexed 
YLJRURXVO\DW୲&IRUK7KHLQLWLDOVHSDUDWHGRUJDQLFEDQGZDVNHSWDW୲&IRUWKH
duration of the second vortexing. At the end of 1 h, the samples were again centrifuged 
for 5 min at 3,000 × rpm at room temperature; the lower organic phase was then 
separated and added to the corresponding initial organic phase with a glass Pasteur 
pipette. With both lower organic phases combined, the solvent was evaporated off by 
nitrogen gas flow. Once all solvent was evaporated, the remaining lipid film was 
dissolved in 100 μL of chloroform-methanol (1:2) and immediately transferred into 2-mL 
glass vials with Teflon screw tops to avoid evaporation until samples were analysed by 
mass spectrometry. Samples were then stored at -୲&DQGUDQRQWKH/742UELWUDS0DVV
Spectrometer within one week of the extraction.  
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Table 2.1. Internal standard mix composition (modified from [34])  
 
 
Internal standards CL, PA, PE, PG, PS and PC were all from Avanti Polar Lipid, 
Alabaster, AL, USA. TAG internal standard originates from Larodan, Malmo, Sweden. 
 
Lipid identification and quantitation using mass spectrometry 
Samples were diluted (1:1) with 1:2 chloroform-methanol supplemented with 0.1% 
ammonium hydroxide for improved ionization efficiency. Samples were injected one at a 
time using a Thermo Orbitrap Velos Mass Spectrometer equipped with HESI-II ion 
source (Thermo Scientific) at a flow rate of 5 μL/ min. The instrument settings for the 










Lipid chain composition 
(number carbons: 
number double bonds 
on fatty acid chain) 








in mix                
(mg/μL) 
Negative 
CL 14:0 / 14:0 / 14:0 /14:0 1274.9000 619.4157 0.10 
FFA 19:0 298.2872 297.2711 0.02 
PA 14:0 / 14:0 614.3920 591.4026 0.10 
PE 14:0 / 14:0 635.4526 634.4448 0.10 
PG 14:0 / 14:0 688.4290 665.4394 0.10 
PS 14:0 / 14:0 701.4240 678.4271 0.02 
Positive TAG 13:0 / 13:0 / 13:0 680.5955 698.6299 0.10 PC 13:0 / 13:0 649.4683 650.4761 0.10 
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Source voltage (kV) 3.9 4 
&DSLOODU\WHPSHUDWXUH୲& 275 275 
Sheath gas flow 5 5 
Aux gas flow 1 1 
FT-MS injection time (ms) 100 500 
FT-MS microscans 3 1 
 
Data were acquired according to the Instrument Method for data-dependent acquisition 
for 5 min in both positive and negative modes by the FT-MS analyser at a resolution of 
100,000 for both MS and MS/MS data. (Table 2.3) 
 
Table 2.3. Instrument method for data-dependent acquisition (from [34]) 
Acquisition time                                  5 min ( with a 0.25 minute delay) 
Instrument polarity Positive Negative 




















































Between each sample, the line was flushed with chloroform-methanol (1:2) mixture until 
the ion detection steadied and returned back into the baseline level. Diluted internal 
standard mix was injected multiple times throughout the acquisition to ensure no 
sensitivity loss throughout the run. 
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          Once all data was acquired, raw files were converted to open format mzXML using 
ProteoWizard MSConvert software (http://proteowizard.sourceforge.net/), the file format 
used by the Lipid Identification Software LipidXplorer (https://wiki.mpi-
cbg.de/lipidx/Main_Page). Data files were then imported into this software using settings 
described in Table 2.4; all lipids in the PA, PC, PE, PI, PS, CL and TAG lipid classes 
were identified with the help of Molecular Fragmentation Query Language (MFQL) files. 
MFQL files were obtained from the LipidXplorer page listed above and aided in the 
identification of lipids by their m/z ratio as well as their fragmentation patterns.  
/LSLG;SORUHU¶VRXWSXt data was then opened under a Microsoft Excel file and all 
detected lipids were quantified by comparison with the intensity of the corresponding 
OLSLGFODVV¶LQWHUQDOVWDQGDUG¶VNQRZQFRQFHQWUDWLRQLQWKHVDPSOH(DFKTXDQWLILHGOLSLG
had a corresponding internal standard from the same lipid class, allowing the calculation 
of molar percentage of each identified lipid species and, therefore, of each lipid class.  
 
Table 2.4. Lipid identification by LipidXplorer import settings for data acquired 
under positive and negative mode (from [34])  
 
Positive mode  Negative mode 
Selection Window (Da) 
Time range (sec.) 
Calibration masses 
             MS 
             MS/MS 
m/z range (m/z-m/z) 
             MS 
             MS/MS 
Resolution (FMHW) 
             MS 
             MS/MS 
Tolerance (ppm) 




























             MS/MS 
Resolution Gradient  (res/(m/z)) 
            MS 
            MS/MS 
Minimum Occupation (0<1) 
             MS 
             MS/MS 


















Purification of the endoplasmic reticulum (ER) from yeast cells 
Reagents and solutions 
1. TSD reduction buffer: 0.1 M Tris/Sulfate (pH 9.4), 10 mM DTT 
2. HEPES lysis buffer: 20 mM HEPES/KOH, pH 6.8, 50 mM KCl, 200 mM sorbitol, 2 
mM EDTA, 1 mM DTT 
3. Spheroplast medium A (pH 7.5): 0.67% yeast nitrogen base (w/o) amino acids, 2 % 
(w/v) glucose, 1 M sorbitol, 20 mM Tris/HCl (pH 7.5) 
4. Spheroplast medium B: 0.67% yeast nitrogen base (w/o) amino acids, 2 % (w/v) 
glucose, 1 M sorbitol 
5. 1.2 M sucrose/ HEPES, 36% (w/w): 7.2 g sucrose + 12.8 ml HEPES lysis buffer 
6. 1.5 M sucrose/ HEPES, 43% (w/w): 8.6 g sucrose + 11.4 ml HEPES lysis buffer 
7. MES buffer 1 (MES breaking buffer): 10 mM MES/Tris (pH 6.9), 12 % (w/w) Ficoll 
400, 0.2 mM EDTA 
8. MES buffer 2: 10 mM MES/Tris (pH 6.9), 8 % (w/w) Ficoll 400, 0.2 mM EDTA 
9. MES buffer 3: 10 mM MES/Tris (pH 6.9), 0.6 M sorbitol, 8 % (w/w) Ficoll 400, 0.2 
mM EDTA 
10. MES buffer 4: 10 mM MES/Tris (pH 6.9), 0.25 M sorbitol, 0.2 mM EDTA 




Wild-type cells were grown in YEPD medium initially containing 2% glucose as carbon 
source, with 0.1% PE21 or without it. Culture was harvested at diauxic phase, checked 
for contamination by bright-field microscopy and used to measure cell density at OD600. 
The non-contaminated wild-type cells were pelleted at 4,000 × g for 5 min at room 
temperature. Cells were then resuspended at 10 OD600 units/ml in TSD reduction buffer, 
incubated for 10 min at room temperature and centrifuged for 5 min at 4,000 × g at room 
temperature. Pelleted cells were then resuspended at 20 OD600 units/ml in Spheroplast 
mediuP$DQGVXSSOHPHQWHGZLWK=\PRO\DVH7DWDFRQFHQWUDWLRQRIȝJSHU
OD600 XQLWVRIFHOOVȝORIHDFKFHOOVXVSHQVLRQZDVWKHQUHPRYHGGLOXWHGLQȝORI
H2O and used to measure the OD600. The remaining cell suspensions were incubated at 
30°C for 30 min and the efficiency of cell wall removal was monitored by measuring the 
OD600. Cell wall digestion was allowed to proceed until the OD600 measurement of the 
diluted cell suspension became 5% of the original value, with the total digestion time not 
exceeding 1 hour. Spheroplasts were then harvested by centrifugation at 1,500 × g for 5 
min at room temperature, followed by resuspending at 1 to 5 OD600 units/ml in 
Spheroplast medium B by gentle swirling of the tube or gentle stirring with a glass rod. 
Spheroplasts were then harvested by centrifugation at 1,500 × g for 5 min at 4°C and then 
resuspended at a concentration of 1,000 OD600 units/ml of ice-cold HEPES lysis buffer 
with freshly-added DTT. Spheroplasts were then homogenized using 20 strokes and 
resulting lysates were centrifuged at 1, 000 × g for 10 min at 4°C. The supernatants 
(S1000) were subjected to another round of centrifugation at 1, 000 × g for 10 min at 4°C, 
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and resulting supernatants were further centrifuged at 27,000 × g for 10 min at 4°C. The 
pelleted membranes (P27,000) were resuspended in 1.0 ml of HEPES lysis buffer (5,000 
OD600 equivalents per ml) using a trimmed 1-ml pipette tip and carefully layered on top 
of a sucrose gradient prepared in advance (2.1 ml of 1.5 M sucrose/HEPES solution was 
deposited to the bottom of a Beckman Ultra-Clear centrifuge tube for the Beckman MLS-
50 rotor, and then overlaid with 2.1 ml of 1.2 M sucrose/HEPES solution). The gradient 
tubes were then placed in the pre-chilled swinging bucket Beckman MLS-50 rotor and 
centrifuged at 100,000 × g (36,000 rpm) for 1 hr at 4°C using the slow acceleration and 
GHFHOHUDWLRQVHWWLQJWRPLQLPL]HGLVUXSWLRQRIJUDGLHQWVJUDGLHQWIUDFWLRQVRIȝO
each were then collected starting from the top of the sucrose gradient and stored at -20°C 
for further analyses. 
 
Isolation of crude mitochondrial fraction from yeast cells  
Reagents 
1. Dithiothreitol (DTT) buffer [100 mM Tris-H2SO4, 10 mM dithiothreitol] 
2. Zymolyase 100T from Arthrobacter luteus (MP Biomedicals) 
3. Zymolyase buffer [1.2 M sorbitol, 20 mM potassium phosphate] 
4. Homogenization buffer [0.6 M sorbitol, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.2% 
(w/v) BSA]  




Cell cultures were combined in pre-weighed centrifuge bottles and cells were pelleted at 
3,000 × g for 5 min at room temperature using a Beckman JA-10 rotor. The cells were 
washed twice with distilled water, followed by the determination of their wet weight. The 
cell pellets were resuspended in 2 ml/g DTT buffer and incubated on a shaker at 80 rpm 
for 20 min at 30ºC. The cells were pelleted as per initial centrifugation, washed in 7 ml/g 
Zymolyase buffer without Zymolyase and pelleted once more. The cells were incubated 
on a shaker at 80 rpm for 45 min at 30ºC with 1 mg/g (wet weight) of Zymolyase-100T in 
7 ml/g Zymolyase buffer. Zymolyase was used because of its well-known strong lytic 
activity required to digest yeast cell wall. The spheroplasts obtained were then spun down 
at 2,200 × g for 8 min at 4ºC. All subsequent steps were carried out on ice or at 4°C with 
the use of cut pipette tips to avoid breaking organelles. The spheroplasts were 
resuspended in 6.5 ml/g ice-cold homogenization buffer and washed by centrifugation at 
2,200 × g for 8 min at 4ºC. The spheroplasts were then mechanically homogenized with 
15 strokes in 6.5 ml/g ice-cold homogenization buffer to disrupt yeast plasma membrane 
for releasing organelles and cytoplasm. Following the homogenization, the cell debris 
was pelleted by centrifuging at 1,500 × g for 5 min at 4ºC using a Beckman JA-17 rotor. 
The resulting lysate supernatant was subjected to centrifugation twice at 3000 × g for 5 
min at 4ºC to pellet the nuclei and 12,000 × g for 15 min at 4ºC. The newly obtained 
pellet contains mostly mitochondria, but also the endoplasmic reticulum (ER), Golgi, 
peroxisomes, lysosomes and vacuoles, whereas the supernatant contains the cytosol, 
microsomes from the ER and vacuoles. The pellet was resuspended in 6.5 ml/g in ice-
cold homogenizing buffer, spun down for 5 min at 3,000 × g at 4ºC to obtain a 
supernatant containing mitochondria, which was then subjected to a spin at 12, 000 × g 
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for 15 min at 4ºC. The resulting pellet was resuspended in 3 ml of SEM to be overlaid 
onto a sucrose gradient. 
 
Purification of mitochondria devoid of microsomal and cytosolic contaminations 
Reagents 
1. SEM buffer [250 mM sucrose, 1 mM EDTA, 10 mM Mops (pH 7.2)] 
2. EM buffer [10 mM Mops (pH 7.2), 1 mM EDTA] 
 
Procedure 
In order to purify yeast mitochondria from the crude mitochondrial fraction, an 
equilibrium density-gradient centrifugation was performed. Yeast mitochondria have a 
density of 1.18 g/cm3 whereas 10% and 50% sucrose respectively have a density of 1.10 
g/cm3 and 1.30 g/cm3. To prepare a sucrose density gradient for the purification of 
mitochondria, 1.5 ml of 60% sucrose in EM buffer was overlaid with 4 ml of 32%, 1.5 ml 
of 23% and 1.5 ml of 15% sucrose in EM buffer, followed by 3 ml of the crude 
mitochondrial suspension. The sucrose density gradient containing the mitochondrial 
suspension was subjected to centrifugation in a Beckman SW41 Ti swinging-bucket rotor 
at 134,000 × g for 60 min at 4ºC.  The mitochondrial band, which was easily 
distinguishable, appeared at the interface between 60% and 32% sucrose. Fractions of 1 
ml were recovered using a cut pipette tip and placed in 1.5 ml Eppendorf tubes and 
frozen at -80ºC until use. In order to quickly freeze the mitochondrial fractions, the 
fractions were immersed, with the aid of long tweezers, in a beaker of isopropyl alcohol 
kept in the -80ºC freezer. 
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Purification of lipid droplets (LDs) from yeast cells 
Reagents and solutions 
1. TSD reduction buffer: 0.1 M Tris/Sulfate (pH 9.4), 10 mM DTT 
2. HEPES lysis buffer: 20 mM HEPES/KOH, pH 6.8, 50 mM KCl, 200 mM sorbitol, 2 
mM EDTA, 1 mM DTT 
3. Spheroplast medium A (pH 7.5): 0.67% yeast nitrogen base (w/o) amino acids, 2 % 
(w/v) glucose, 1 M sorbitol, 20 mM Tris/HCl (pH 7.5) 
4. Spheroplast medium B: 0.67% yeast nitrogen base (w/o) amino acids, 2 % (w/v) 
glucose, 1 M sorbitol 
5. 1.2 M sucrose/ HEPES, 36% (w/w): 7.2 g sucrose + 12.8 ml HEPES lysis buffer 
6. 1.5 M sucrose/ HEPES, 43% (w/w): 8.6 g sucrose + 11.4 ml HEPES lysis buffer 
7. MES buffer 1 (MES breaking buffer): 10 mM MES/Tris (pH 6.9), 12 % (w/w) Ficoll 
400, 0.2 mM EDTA 
8. MES buffer 2: 10 mM MES/Tris (pH 6.9), 8 % (w/w) Ficoll 400, 0.2 mM EDTA 
9. MES buffer 3: 10 mM MES/Tris (pH 6.9), 0.6 M sorbitol, 8 % (w/w) Ficoll 400, 0.2 
mM EDTA 
10. MES buffer 4: 10 mM MES/Tris (pH 6.9), 0.25 M sorbitol, 0.2 mM EDTA 
11. KPi buffer (pH 7.4): 20 mM KH2PO4/KOH (pH 7.4), 1.2 M sorbitol 
 
Procedure 
Wild-type cells were grown in YEPD medium initially containing 2% glucose as carbon 
source, with 0.1% PE21 or without it. Cultures were harvested at diauxic phase, checked 
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for contamination by bright-field microscopy and used to measure cell density at OD600. 
The non-contaminated wild-type cells were pelleted at 4,000 × g for 5 min at room 
temperature. The cells were then washed once with distilled water and resuspended in the 
TSD reduction buffer at 10 x OD600 units/ml. Following a 10-min incubation at room 
temperature, the cells were pelleted by centrifugation at 4,000 × g for 5min at room 
temperature and then washed once in Spheroplasts medium A. The cells were then 
resuspended in Spheroplasts medium A at 20 × OD600 units/ml, supplemented with 
Zymolyase 17DWDFRQFHQWUDWLRQRIȝJSHU2'600 units of cells, and incubated at 
30°C for 45 min on a shaker set at 75 rpm. Spheroplasts were then pelleted by 5min 
centrifugation at 1,500 × g at room temperature, resuspended in the ice-cold Spheroplasts 
medium B at 5 × OD600 units/ml using pipettes with cut tips, and centrifuged for 5 min at 
1,500 × g at 4oC. Spheroplasts were then washed twice by resuspending the pellets in ice-
cold KPi buffer at a concentration of 5 OD600 units/ml followed by centrifugation for 5 
min at 1,500 × g at 4oC. After the second wash and centrifugation step, clean spheroplasts 
were resuspended in ice-cold MES Buffer 1 at a concentration of 1,000 OD600 units/ml 
using pipettes with non-cut tips. Spheroplasts were then lysed in a homogenizer using 20 
strokes at 4°C. Lysates were centrifuged for 5 min at 5,000 × g at 4°C and the resulting 
supernatants (S5,000) were transferred to pre-chilled centrifuge tubes kept on ice. LDs 
were then purified by subjecting the spheroplast lysates to a series of flotation gradient 
centrifugations using a MLS 50 swinging bucket rotor (Beckman). The first flotation 
gradient was prepared by placing 2.5 ml of the S5,000 fraction to the bottom of a centrifuge 
tube (Ultra-Clear Beckman tubes for MLS 50 rotor) and overlaying it with 2.5 ml of ice-
cold MES Buffer 1. Following 1 hour centrifugation at 100,000 × g (36,000 rpm) at 4°C,  
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the floating layer from the top portions of the gradients was collected with a cut tip and 
transferred to the bottom of a new centrifuge tube, which was then supplemented with 
MES buffer 2 to a total volume of 2.5 ml and gently mixed by pipetting. Resulting 
suspension was overlaid with 2.5 ml of ice-cold MES buffer 2 and then centrifuged for 1 
hr at 100,000 × g (36,000 rpm) at 4°C. The floating layer from the top portions of the 
gradients was again collected with a cut tip and transferred to the bottom of a new 
centrifuge tube, which was then supplemented with MES buffer 3 to a total volume of 2.5 
ml and gently mixed by pipetting. Resulting suspension was overlaid with 2.5 ml of ice-
cold MES buffer 4 and then centrifuged for 1 hr at 100,000 × g (36,000 rpm) at 4°C. The 
floating layer from the top portions of the gradients was collected with a cut tip and 




VBA. All data are presented as mean ± SEM. The p values were calculated with the help 
of GraphPad t test calculator using an unpaired two-tailed t test.  
 
2.3 Results 
Lipid metabolism and interorganellar transport in mitochondria, the endoplasmic 
reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. cerevisiae involve 
numerous steps, each catalyzed by a known enzyme or several enzymes (Figure 2.1).  
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2.3.1 PE21 decreases the concentration of triacylglycerol (TAG) in chronologically 
aging yeast  
Using mass-spectrometric quantitative analysis, I compared the concentrations of 
different classes of lipids in cells of chronologically aging yeast exposed to PE21 or 
remained untreated. I found that PE21 decreases the concentration of the neutral lipid 
TAG in chronologically aging yeast (Figure 2.2). There are three different ways to 
decrease the concentration of TAG in yeast treated with PE21. These ways include the 
following: 1) decrease Are1p and/or Are2p concentration and activity; 2) decrease Dga1p 
and/or Are2p concentration and activity; or 3) increase Tgl1p, Tgl3p, Tgl4p and/or Tgl5p 
concentration and activity (Figure 2.1). Future studies should address the importance of 
the observed decreased TAG concentration in the aging-delaying ability of PE21 by 
answering the following three questions: 1) Will single-gene-deletion mutations 
eliminating Are1p, Are2p, Dga1p or Lro1p (each of which is expected to further decrease 
TAG concentration) enhance the aging-delaying effect of PE21? 2) Will single-gene-
deletion mutations eliminating Tgl1p, Tgl3p, Tgl4p or Tgl5p (each of which is expected 
to increase TAG concentration) weaken/eliminate the aging-delaying effect of PE21? 3) 
What are the concentrations of TAG (and other lipid classes) in cells of each of these 
single-gene-deletion mutants?   
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Figure 2.1. Lipid metabolism and interorganellar transport in mitochondria, the 
endoplasmic reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. 
cerevisiae. [25, 26, 27] 
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Figure 2.2. PE21 decreases the concentration of the neutral lipid triacylglycerol 
(TAG) in chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE21. Cells 
were recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, 
as well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods. Based on these data, the concentrations of TAG 
were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
2.3.2 PE21 does not alter the concentration of phosphatidic acid (PA) in 
chronologically aging yeast 
I found that PE21 does not change the concentration of PA in chronologically 
aging yeast (Figure 2.3). There are three different ways to keep PA concentration 
unchanged in yeast treated with PE21. These ways include the following: 1) not to 
change Ale1p, Slc1p, Pah1p, Lpp1p, Cds1p and/or Ups1p concentration/activity; 2) 
increase Ale1p and/or Slc1p and increase Pah1p, Lpp1p, Cds1p and/or Ups1p 
concentration/activity; or 3) decrease Ale1p and/or Slc1p and decrease Pah1p, Lpp1p, 
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Cds1p and/or Ups1p concentration/activity (Figure 2.1). Future studies should address 
the importance of the observed lack of the effect of PE21 on PA concentration in the 
aging-delaying ability of this plant extract by answering the following three questions: 1) 
Will single-gene-deletion mutations eliminating any of the enzymes involved in PA 
synthesis (i.e. Ale1p or Slc1p; each of which is expected to decrease PA concentration) 
influence the aging-delaying effect of PE21? 2) Will single-gene-deletion mutations 
eliminating any of the enzymes involved in PA consumption or transport to mitochondria 
(i.e. Pah1p, Lpp1p, Cds1p and/or Ups1p; each of which is expected to increase PA 
concentration) influence the aging-delaying effect of PE21? 3) What are the 
concentrations of PA (and other lipid classes) in cells of each of these single-gene-
deletion mutants?   
 
Figure 2.3. PE21 does not change the concentration of phosphatidic acid (PA) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
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rich YP medium initially containing 2% glucose with or without PE21. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods. Based on these data, the concentrations of PA were 
calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
2.3.3 PE21 increases the concentration of phosphatidylserine (PS) in 
chronologically aging yeast 
I found that PE21 increases the concentration of PS in chronologically aging yeast 
(Figure 2.4). There are two different ways to increase PS concentration in yeast treated 
with PE21. These ways include the following: 1) increase Cds1p and/or Cho1p 
concentration/activity; or 2) decrease Psd1p concentration/activity (Figure 2.1). Future 
studies should address the importance of the observed increased PS concentration in the 
aging-delaying ability of PE21 by answering the following three questions: 1) Will 
single-gene-deletion mutations eliminating any of the enzymes involved in PS synthesis 
(i.e. Cds1p or Cho1p; each of which is expected to decrease PS concentration) 
weaken/eliminate the aging-delaying effect of PE21? 2) Will a single-gene-deletion 
mutation eliminating an enzyme involved in PS consumption (i.e. Psd1p; which is 
expected to further increase PS concentration) enhance the aging-delaying effect of 
PE21? 3) What are the concentrations of PS (and other lipid classes) in cells of each of 








Figure 2.4. PE21 increases the concentration of phosphatidylserine (PS) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE21. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods. Based on these data, the concentrations of PS were 
calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
2.3.4 PE21 increases the concentration of phosphatidylethanolamine (PE) in 
chronologically aging yeast 
I found that PE21 increases the concentration of PE in chronologically aging yeast 
(Figure 2.5). There are two different ways to increase PE concentration in yeast treated 
with PE21. These ways include the following: 1) increase Psd1p concentration/activity; 
or 2) decrease Cho2p and/or Opi3p concentration/activity (Figure 2.1). Future studies 
should address the importance of the observed increased PE concentration in the aging-
delaying ability of PE21 by answering the following three questions: 1) Will a single-
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gene-deletion mutation eliminating an enzyme involved in PE synthesis (i.e. Psd1p; 
which is expected to decrease PE concentration) weaken/eliminate the aging-delaying 
effect of PE21? 2) Will single-gene-deletion mutations eliminating any of the enzymes 
involved in PE consumption (i.e. Cho2p and/or Opi3p; each of which is expected to 
increase PE concentration) enhance the aging-delaying effect of PE21? 3) What are the 




Figure 2.5. PE21 increases the concentration of phosphatidylethanolamine (PE) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE21. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods. Based on these data, the concentrations of PE were 
calculated in mol%. Data are presented as means ± SEM (n = 2). 
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2.3.5 PE21 increases the concentration of phosphatidylcholine (PC) late in life of 
chronologically aging yeast 
I found that PE21 increases the concentration of PC late in life of chronologically aging 
yeast (Figure 2.6). There are two different ways to increase PC concentration in yeast 
treated with PE21. These ways include the following: 1) increase Cho2p and/or Opi3p 
concentration/activity; or 2) decrease Taz1p concentration/activity (Figure 2.1). Future 
studies should address the importance of the late-in-life increased PC concentration in the 
aging-delaying ability of PE21 by answering the following three questions: 1) Will 
single-gene-deletion mutations eliminating enzymes involved in PC synthesis (i.e. Cho2p 
and/or Opi3p; each of which is expected to decrease PC concentration) weaken/eliminate 
the aging-delaying effect of PE21? 2) Will a single-gene-deletion mutation eliminating an 
enzyme involved in PC consumption (i.e. Taz1p; which is expected to increase PC 
concentration) enhance the aging-delaying effect of PE21? 3) What are the 




Figure 2.6. PE21 increases the concentration of phosphatidylcholine (PC) late in life 
of chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE21. Cells 
were recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, 
as well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods. Based on these data, the concentrations of PC were 
calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
2.3.6 PE21 increases the concentration of phosphatidylinositol (PI) late in life of 
chronologically aging yeast 
I found that PE21 increases the concentration of PI late in life of chronologically 
aging yeast (Figure 2.7). The only way to increase PC concentration in yeast treated with 
PE21 consists in increasing Cds1p and/or Pis1p concentration/activity (Figure 2.1). 
Future studies should address the importance of the late-in-life increased PI concentration 
in the aging-delaying ability of PE21 by answering the following two questions: 1) Will 
single-gene-deletion mutations eliminating enzymes involved in PI synthesis (i.e. Cds1p 
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and/or Pis1p; each of which is expected to decrease PI concentration) weaken/eliminate 
the aging-delaying effect of PE21? 2) What are the concentrations of PI (and other lipid 
classes) in cells of each of these single-gene-deletion mutants? 
 
Figure 2.7. PE21 increases the concentration of phosphatidylinositol (PI) late in life 
of chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE21. Cells 
were recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, 
as well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods. Based on these data, the concentrations of PI were 
calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
2.3.7 PE21 decreases the concentration of cardiolipin (CL) in chronologically 
aging yeast 
I found that PE21 decreases the concentration of CL (a signature lipid of the inner 
mitochondrial membrane) in chronologically aging yeast (Figure 2.8). The only way to 
increase CL concentration in yeast treated with PE21 consists in decreasing Ups1p, 
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Tam41p, Pgs1p, Gep4p, Crd1p, Cld1p and/or Taz1p concentration/activity (Figure 2.1). 
Future studies should address the importance of the decreased CL concentration in the 
aging-delaying ability of PE21 by answering the following two questions: 1) Will single-
gene-deletion mutations eliminating enzymes involved in CL synthesis (i.e. Ups1p, 
Tam41p, Pgs1p, Gep4p, Crd1p, Cld1p and/or Taz1p; each of which is expected to further 
decrease CL concentration) enhance the aging-delaying effect of PE21? 2) What are the 
concentrations of CL (and other lipid classes) in cells of each of these single-gene-
deletion mutants? 
 
Figure 2.8. PE21 decreases the concentration of cardiolipin (CL) in chronologically 
aging yeast. The wild-type strain of yeast was cultured in the nutrient-rich YP medium 
initially containing 2% glucose with or without PE21. Cells were recovered on days 1, 2, 
3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as well as their mass 
spectrometric identification and quantitation, were carried out as described in Materials 
and Methods. Based on these data, the concentrations of CL were calculated in mol%. 
Data are presented as means ± SEM (n = 2). 
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2.3.8 PE21 differently affect the concentrations of various classes of lipids in the 
ER, mitochondria and LDs of chronologically aging yeast 
Only CL is confined to a single type of organelles, being a signature lipid class of 
mitochondria (Figure 2.1). All other classes of lipids reside in several types of 
organelles. Indeed, glycerol phospholipids other than CL can be found in the ER, 
mitochondria and LDs (Figure 2.1), whereas TAG can be detected in the ER and LDs 
(Figure 2.1). Therefore, I used quantitative mass spectrometry to assess how PE21 
impacts lipidomes of the ER, mitochondria and LDs purified from chronologically aging 
yeast. Each of these types of organelles was purified from yeast cells that were recovered 
on day 2 of culturing, at diauxic growth phase. I found that PE21 increases the 
concentration of PE, decreases the concentration of TAG and does not alter the 
concentrations of other lipid classes in the ER (Figure 2.9). PE21 also differently 
affected the abundance of several lipid classes in mitochondria by increasing the 
concentration of PE, decreasing the concentrations of PG and CL, and not altering the 
concentrations of other lipid classes (Figure 2.10). I found no effect of PE21 on the 
lipidome of LDs, which contains mainly TAG and traces of PC (Figure 2.11).  
 
Figure 2.9. PE21 alters the concentrations of some lipid classes in the ER of 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
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rich YP medium initially containing 2% glucose with or without PE21. Cells were 
recovered on day 2 of culturing. The ER was purified as described in Materials and 
Methods. Extraction of lipids, as well as their mass spectrometric identification and 
quantitation, were carried out as described in Materials and Methods. Based on these 
data, the concentrations of different lipid classes were calculated in mol%. 
 
 
Figure 2.10. PE21 alters the concentrations of some lipid classes in mitochondria of 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE21. Cells were 
recovered on day 2 of culturing. Mitochondria were purified as described in Materials 
and Methods. Extraction of lipids, as well as their mass spectrometric identification and 
quantitation, were carried out as described in Materials and Methods. Based on these 
data, the concentrations of different lipid classes were calculated in mol%. 
 
 
Figure 2.11. PE21 does not alter the concentrations of lipids in LDs of 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
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rich YP medium initially containing 2% glucose with or without PE21. Cells were 
recovered on day 2 of culturing. LDs were purified as described in Materials and 
Methods. Extraction of lipids, as well as their mass spectrometric identification and 
quantitation, were carried out as described in Materials and Methods. Based on these 
data, the concentrations of different lipid classes were calculated in mol%. 
 
2.4 Discussion 
My data on how PE21 influences the concentrations of different lipid classes in 
cells of chronologically aging yeast suggest that this aging-delaying plant extract alters 
the relative rates of PA flow into the synthesis of other lipid classes as follows: 1) PE21 
decreases the rate of PA flow into the synthesis of TAG in the ER; 2) PE21 increases the 
rate of PA flow into the synthesis of glycerol phospholipids (i.e. PS, PE, PC and PI) in 
the ER and mitochondria; and 3) PE21decreases the rate of PA flow into the synthesis of 
CL in mitochondria (Figure 2.12). Such re-wiring of PA conversion into TAG, glycerol 
phospholipids and CL delays aging by a mechanism that remains to be established. I 
speculate that this mechanism may affect several longevity-defining processes in 
chronologically aging yeast, as described below.  
First, the observed reduction in the concentration of CL in mitochondria of yeast 
cells treated with PE21 may cause the specific changes in the age-related chronology of 
mitochondrial functionality seen in these cells. [35] These changes affect mitochondrial 
respiration, mitochondrial membrane potential, mitochondrially produced ROS and 
stability of mitochondrial DNA. [35] To validate this hypothesis, it needs to be assessed 
how genetic manipulations (such as single-gene-deletions and amplified gene expression) 
that decrease or increase the concentration of CL in the mitochondrial membrane impact 
mitochondrial functionality and the ability of PE21 to delay aging.  
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Second, the observed increase in the concentrations of glycerol phospholipids in 
the ER of yeast cells treated with PE21 may cause the increased resistance of these cells 
to chronic oxidative and thermal stresses. [35] To test the validity of this hypothesis, it is 
necessary to examine how genetic manipulations (such as single-gene-deletions and 
elevated gene expression) that decrease or increase the concentration of glycerol 
phospholipids in the ER membrane affect stress resistance and the efficiency with which 
PE21 delays aging.  
Third, one of the outcomes of the observed re-wiring of lipid metabolism and 
transport in yeast cells treated with PE21 may be a decrease in the cellular concentrations 
of FFA, a class of lipids whose attachment to PA initiates all three major routes of lipid 
metabolism in the ER, mitochondria and LDs (Figure 2.12). FFA are known to trigger an 
age-related form of programmed cell death called liponecrosis. [36, 37]  To validate this 
hypothesis, the concentrations of FFA in yeast cells treated with PE21 need to be 
compared to those in cells that remained untreated. Furthermore, it needs to be examined 
how genetic manipulations (such as single-gene-deletions and amplified gene expression) 
that decrease or increase the concentrations of FFA in yeast cells impact the efficiency of 
liponecrosis and the ability of PE21 to delay aging.  
   My quantitative mass-spectrometric analysis of various lipid classes from three 
different types of purified organelles (such as the ER, mitochondria and LDs) was 
performed for yeast cells that were recovered on day 2 of culturing, at diauxic growth 
phase. This analysis has revealed that an increase in the concentration of PE observed in 
the whole-cell lipidome of PE21-treated cells on day 2 of culturing was due, in part, to 
the increase of PE abundance in both the ER and mitochondria. It remains to be 
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determined if the increase in the concentration of total cellular PE was also due to an 
increase (if any) of PE abundance in the plasma membrane (PM). Furthermore, it needs 
to be assessed what portion of total lipids are contributed by the ER, mitochondria and 
PM. Furthermore, this analysis of purified organelles has revealed that on day 2 of cell 
culturing PE21 causes a decrease in TAG in the ER, but not in LDs. Moreover, this 
analysis of purified organelles has confirmed that on day 2 of cell culturing PE21 causes 
a decrease in CL in the mitochondrial membranes. I therefore concluded that the 
quantitative mass-spectrometric analysis of various lipid classes from different types of 
purified organelles is a powerful tool for revealing the age-related chronology of changes 
in lipid dynamics in yeast cells treated with PE21. Because my findings imply that 
various lipid classes undergo different kinds of changes in their concentrations in these 
cells at different stages of the aging process, in the future this powerful tool is expected to 
be used intensively for uncovering mechanisms that underlie the essential role of lipid 




Figure 2.12.  A hypothetical model of how PE21 alters the relative rates of PA flow 
into the synthesis of other lipid classes. PE21: 1) decreases the rate of PA flow into the 
synthesis of TAG in the ER; 2) increases the rate of PA flow into the synthesis of 
glycerol phospholipids (i.e. PS, PE, PC and PI) in the ER and mitochondria; and 3) 
decreases the rate of PA flow into the synthesis of CL in mitochondria.           
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3 An aging-delaying plant extract PE4 remodels cellular lipidome of 
chronologically aging yeast  
 
3.1 Abstract 
Recent studies from the Titorenko laboratory have identified 6 plant extracts that delay 
chronological aging of S. cerevisiae. All these plant extracts are significantly more 
efficient aging-delaying interventions than any of the currently known anti-aging 
chemicals. One of these plant extracts is called PE4. Recent unpublished findings of the 
Titorenko laboratory suggest that some aspects of lipid metabolism and interorganellar 
transport may play essential roles in the delay of aging by PE4. In studies described in 
this chapter of my Thesis, I have used mass-spectrometric quantitative analysis to 
compare the concentrations of different classes of lipids in cells of chronologically aging 
yeast exposed to PE4 or remained untreated. My findings indicate that PE4 alters the 
relative rates of phosphatidic acid (PA) formation and of PA flow into the synthesis of 
other lipids as follows: 1) it intensifies PA synthesis from free fatty acids (FFA) in the 
endoplasmic reticulum (ER); 2) it decreases the rate of PA flow into the synthesis of 
triacylglycerols (TAG) in the ER; 3) it increases the rate of PA flow into the synthesis of 
phosphatidylethanolamine (PE) in mitochondria; 4) it increases the rate of PA flow into 
the synthesis of phosphatidylinositol (PI) in the ER; and 5) it increases the rate of PA 
flow into the synthesis of cardiolipin (CL) in mitochondria. Such re-wiring of PA 
synthesis and its conversion into TAG, PE, PI and CL delays aging by a mechanism that 
remains to be established. 
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3.2 Materials and Methods 
 
Yeast strains, media and growth conditions 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATD his3'1 leu2'0 lys2'0 
ura3'0) from Thermo Scientific/Open Biosystems was grown in a synthetic minimal 
YNB medium (0.67% Yeast Nitrogen Base without amino acids) initially containing 2% 
glucose and supplemented with 20 mg/l histidine, 30 mg/l leucine, 30 mg/l lysine and 20 
mg/l uracil. Cells were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer 
IODVNVDWD³IODVNYROXPHPHGLXPYROXPH´UDWLRRIThe stock solution of aging-
delaying plant extract 4 (PE4) in ethanol was made on the day of adding this PE to cell 
cultures. This stock solution was added to growth medium immediately following cell 
inoculation into the medium. The final concentration of PE4 in growth medium was 
0.5%. 
 
Lipid extraction, identification and quantitation using mass spectrometry 




VBA. All data are presented as mean ± SEM. The p values were calculated with the help 





Lipid metabolism and interorganellar transport in mitochondria, the endoplasmic 
reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. cerevisiae involve 
numerous steps, each catalyzed by a known enzyme or several enzymes (Figure 3.1).  
 
3.3.1 PE4 decreases the concentration of triacylglycerol (TAG) in chronologically 
aging yeast  
Using mass-spectrometric quantitative analysis, I compared the concentrations of 
different classes of lipids in cells of chronologically aging yeast exposed to PE4 or 
remained untreated. I found that PE4 decreases the concentration of the neutral lipid TAG 
in chronologically aging yeast (Figure 3.2).  
 
Figure 3.1. Lipid metabolism and interorganellar transport in mitochondria, the 
endoplasmic reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. 




Figure 3.2. PE4 decreases the concentration of the neutral lipid triacylglycerol 
(TAG) in chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE4. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of TAG were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
3.3.2 PE4 increases the concentration of phosphatidic acid (PA) in chronologically 
aging yeast 
I found that PE4 elevates the concentration of PA in chronologically aging yeast 
(Figure 3.3).  
 
3.3.3 PE4 does not alter the concentration of phosphatidylserine (PS) in 
chronologically aging yeast 
I found that PE4 does not change the concentration of PS in chronologically aging 
yeast (Figure 3.4).  
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Figure 3.3. PE4 increases the concentration of phosphatidic acid (PA) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE4. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PA were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
Figure 3.4. PE4 does not alter the concentration of phosphatidylserine (PS) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE4. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PS were calculated in mol%. Data are presented as means ± SEM (n = 2). 
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3.3.4 PE4 increases the concentration of phosphatidylethanolamine (PE) late in life 
of chronologically aging yeast 
I found that PE4 increases the concentration of PE late in life of chronologically 
aging yeast (Figure 3.5).  
 
Figure 3.5. PE4 increases the concentration of phosphatidylethanolamine (PE) late 
in life of chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE4. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PE were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
3.3.5 PE4 does not alter the concentration of phosphatidylcholine (PC) in 
chronologically aging yeast 
I found that PE4 has no effect on the concentration of PC in chronologically aging 
yeast (Figure 3.6).  
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Figure 3.6. PE4 does not alter the concentration of phosphatidylcholine (PC) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE4. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PC were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
3.3.6 PE4 increases the concentration of phosphatidylinositol (PI) in 
chronologically aging yeast 
I found that PE4 causes an increase in the concentration of PI in chronologically 
aging yeast (Figure 3.7).  
 
3.3.7 PE4 increases the concentration of cardiolipin (CL) in chronologically aging 
yeast 
I found that PE4 increases the concentration of CL (a signature lipid of the inner 




Figure 3.7. PE4 increases the concentration of phosphatidylinositol (PI) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE4. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PI were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
 
Figure 3.8. PE4 increases the concentration of cardiolipin (CL) in chronologically 
aging yeast. The wild-type strain of yeast was cultured in the nutrient-rich YP medium 
initially containing 2% glucose with or without PE4. Cells were recovered on days 1, 2, 
3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as well as their mass 
spectrometric identification and quantitation, were carried out as described in Materials 
and Methods of chapter 2. Based on these data, the concentrations of CL were calculated 
in mol%. Data are presented as means ± SEM (n = 2). 
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3.4 Discussion 
My data on how PE4 influences the concentrations of different lipid classes in 
cells of chronologically aging yeast suggest that this aging-delaying plant extract alters 
the relative rates of phosphatidic acid (PA) formation and of PA flow into the synthesis 
of other lipids as follows: 1) it intensifies PA synthesis from FFA in the ER; 2) it 
decreases the rate of PA flow into the synthesis of TAG in the ER; 3) it increases the rate 
of PA flow into the synthesis of PE in mitochondria; 4) it increases the rate of PA flow 
into the synthesis of PI in the ER; and 5) it increases the rate of PA flow into the 
synthesis of CL in mitochondria (Figure 3.9). Such re-wiring of PA synthesis and its 
conversion into TAG, PE, PI and CL delays aging by a mechanism that remains to be 
established. I speculate that this mechanism may affect several longevity-defining 
processes in chronologically aging yeast, as described below.  
First, the observed increase in the concentration of CL in mitochondria of yeast 
cells treated with PE4 may cause certain changes in the age-related chronology of 
mitochondrial functionality seen in these cells. [35] These changes involve alterations in 
mitochondrial respiration, mitochondrial membrane potential, mitochondrially produced 
ROS and stability of mitochondrial DNA. [35] To validate this hypothesis, it needs to be 
assessed how genetic manipulations (such as single-gene-deletions and amplified gene 
expression) that decrease or increase the concentration of CL in the mitochondrial 
membrane impact mitochondrial functionality and the ability of PE4 to delay aging.  
Second, the observed increase in the concentrations of two glycerol 
phospholipids, PE and PI, in yeast cells treated with PE4 may cause the increased 
resistance of these cells to chronic oxidative and thermal stresses. [35] To test the validity  
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Figure 3.9.  A hypothetical model of how PE4 alters the relative rates of PA 
synthesis and of PA flow into the synthesis of other lipid classes. PE4: 1) intensifies 
PA synthesis from FFA in the ER; 2) decreases the rate of PA flow into the synthesis of 
TAG in the ER; 3) increases the rate of PA flow into the synthesis of PE in mitochondria; 
4) increases the rate of PA flow into the synthesis of PI in the ER; and 5) increases the 
rate of PA flow into the synthesis of CL in mitochondria. 
 
of this hypothesis, it is necessary to examine how genetic manipulations (such as single-
gene-deletions and elevated gene expression) that decrease or increase the concentration 
of PE and PI affect stress resistance and the efficiency with which PE4 delays aging.  
Third, one of the outcomes of the observed re-wiring of lipid metabolism and 
transport in yeast cells treated with PE4 may be a decrease in the cellular concentrations 
of FFA, a class of lipids whose incorporation into PA initiates all three major routes of 
lipid metabolism in the ER, mitochondria and LDs (Figure 3.9). FFA are known to 
trigger an age-related form of programmed cell death called liponecrosis. [36, 37]  To 
validate this hypothesis, the concentrations of FFA in yeast cells treated with PE4 need to 
be compared to those in cells that remained untreated. Furthermore, it needs to be 
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examined how genetic manipulations (such as single-gene-deletions and amplified gene 
expression) that decrease or increase the concentrations of FFA in yeast cells impact the 
efficiency of liponecrosis and the ability of PE4 to delay aging.  
   Future studies also need to use quantitative mass spectrometry to monitor an 
age-related chronology of changes in various lipid classes extracted from three different 
types of purified organelles (such as the ER, mitochondria and LDs). These studies will 
allow a critical validation of my hypothesis on how PE4 alters the relative rates of PA 





4 An aging-delaying plant extract PE5 remodels cellular lipidome of 
chronologically aging yeast  
 
4.1 Abstract 
Another aging-delaying plant extract recently discovered by the Titorenko laboratory is 
called PE5. Recent unpublished studies in the Titorenko laboratory suggest that some 
aspects of lipid metabolism and interorganellar transport may play essential roles in the 
delay of aging by PE5. In studies described in this chapter of my Thesis, I have used 
mass-spectrometric quantitative analysis to compare the concentrations of different 
classes of lipids in cells of chronologically aging yeast exposed to PE5 or remained 
untreated. My findings indicate that PE5 alters the relative rates of phosphatidic acid 
(PA) formation and of PA flow into the synthesis of other lipids as follows: 1) it 
promotes PA synthesis from free fatty acids (FFA) in the endoplasmic reticulum (ER); 2) 
it decreases the rate of PA flow into the synthesis of triacylglycerols (TAG) in the ER; 3) 
it decreases the rates of PA flow into the synthesis of phosphatidylcholine (PC) and 
phosphatidylinositol (PI) in the ER, as well as into the synthesis of 
phosphatidylethanolamine (PE) in mitochondria; and 4) it increases the rate of PA flow 
into the synthesis of cardiolipin (CL) in mitochondria. Such re-wiring of PA synthesis 
and its conversion into TAG, PC, PI, PE and CL delays aging by a mechanism that 
remains to be established. 




4.2 Materials and Methods 
 
Yeast strains, media and growth conditions 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATD his3'1 leu2'0 lys2'0 
ura3'0) from Thermo Scientific/Open Biosystems was grown in a synthetic minimal 
YNB medium (0.67% Yeast Nitrogen Base without amino acids) initially containing 2% 
glucose and supplemented with 20 mg/l histidine, 30 mg/l leucine, 30 mg/l lysine and 20 
mg/l uracil. Cells were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer 
IODVNVDWD³IODVNYROXPHPHGLXPYROXPH´UDWLRRIThe stock solution of aging-
delaying plant extract 5 (PE5) in ethanol was made on the day of adding this PE to cell 
cultures. This stock solution was added to growth medium immediately following cell 
inoculation into the medium. The final concentration of PE5 in growth medium was 
0.5%. 
 
Lipid extraction, identification and quantitation using mass spectrometry 




VBA. All data are presented as mean ± SEM. The p values were calculated with the help 





Lipid metabolism and interorganellar transport in mitochondria, the endoplasmic 
reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. cerevisiae involve 
numerous steps, each catalyzed by a known enzyme or several enzymes (Figure 4.1).  
 
4.3.1 PE5 decreases the concentration of triacylglycerol (TAG) in chronologically 
aging yeast  
Using mass-spectrometric quantitative analysis, I compared the concentrations of 
different classes of lipids in cells of chronologically aging yeast exposed to PE5 or 
remained untreated. I found that PE5 decreases the concentration of the neutral lipid TAG 
in chronologically aging yeast (Figure 4.2).  
 
Figure 4.1. Lipid metabolism and interorganellar transport in mitochondria, the 
endoplasmic reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. 




Figure 4.2. PE5 decreases the concentration of the neutral lipid triacylglycerol 
(TAG) in chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE5. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of TAG were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
4.3.2 PE5 causes an increase in the concentration of phosphatidic acid (PA) in 
chronologically aging yeast 
I found that PE5 increases the concentration of PA in chronologically aging yeast 
(Figure 4.3).  
 
4.3.3 PE5 does not change the concentration of phosphatidylserine (PS) in 
chronologically aging yeast 
I found that PE5 has no effect on the concentration of PS in chronologically aging 
yeast (Figure 4.4).  
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Figure 4.3. PE5 increases the concentration of phosphatidic acid (PA) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE5. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PA were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
Figure 4.4. PE5 does not alter the concentration of phosphatidylserine (PS) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE5. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PS were calculated in mol%. Data are presented as means ± SEM (n = 2). 
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4.3.4 PE5 decreases the concentration of phosphatidylethanolamine (PE) in 
chronologically aging yeast 
I found that PE5 causes a decrease of the concentration of PE in chronologically 
aging yeast (Figure 4.5).  
 
Figure 4.5. PE5 decreases the concentration of phosphatidylethanolamine (PE) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE5. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PE were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
4.3.5 PE5 decreases the concentration of phosphatidylcholine (PC) in 
chronologically aging yeast 
I found that PE5 reduces the concentration of PC in chronologically aging yeast 
(Figure 4.6).  
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Figure 4.6. PE5 decreases the concentration of phosphatidylcholine (PC) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE5. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PC were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
4.3.6 PE5 reduces the concentration of phosphatidylinositol (PI) in chronologically 
aging yeast 
I found that PE5 decreases the concentration of PI in chronologically aging yeast 
(Figure 4.7).  
 
4.3.7 PE5 increases the concentration of cardiolipin (CL) in chronologically aging 
yeast 
I found that PE5 causes a rise in the concentration of CL (a signature lipid of the 
inner mitochondrial membrane) in chronologically aging yeast (Figure 4.8).  
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Figure 4.7. PE5 decreases the concentration of phosphatidylinositol (PI) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE5. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PI were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
 
Figure 4.8. PE5 increases the concentration of cardiolipin (CL) in chronologically 
aging yeast. The wild-type strain of yeast was cultured in the nutrient-rich YP medium 
initially containing 2% glucose with or without PE5. Cells were recovered on days 1, 2, 
3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as well as their mass 
spectrometric identification and quantitation, were carried out as described in Materials 
and Methods of chapter 2. Based on these data, the concentrations of CL were calculated 
in mol%. Data are presented as means ± SEM (n = 2). 
 71 
4.4 Discussion 
My data on how PE5 influences the concentrations of different lipid classes in 
cells of chronologically aging yeast suggest that this aging-delaying plant extract alters 
the relative rates of phosphatidic acid (PA) formation and of PA flow into the synthesis 
of other lipids as follows: 1) it promotes PA synthesis from FFA in the ER; 2) it 
decreases the rate of PA flow into the synthesis of TAG in the ER; 3) it decreases the rate 
of PA flow into the synthesis of PE in mitochondria; 4) it decreases the rate of PA flow 
into the synthesis of PC and PI in the ER; and 5) it increases the rate of PA flow into the 
synthesis of CL in mitochondria (Figure 4.9). Such re-wiring of PA synthesis and its 
conversion into TAG, PE, PC, PI and CL delays aging by a mechanism that remains to be 
established. I speculate that this mechanism may affect several longevity-defining 
processes in chronologically aging yeast, as described below.  
First, the observed increase in the concentration of CL in mitochondria of yeast 
cells treated with PE5 may cause certain changes in the age-related chronology of 
mitochondrial functionality seen in these cells. [35] These changes involve alterations in 
mitochondrial respiration, mitochondrial membrane potential, mitochondrially produced 
ROS and stability of mitochondrial DNA. [35] To validate this hypothesis, it needs to be 
assessed how genetic manipulations (such as single-gene-deletions and amplified gene 
expression) that decrease or increase the concentration of CL in the mitochondrial 
membrane impact mitochondrial functionality and the ability of PE5 to delay aging.  
Second, the observed decrease in the concentrations of three glycerol 
phospholipids, PE, PC and PI, in yeast cells treated with PE5 may cause the increased 
resistance of these cells to chronic oxidative and thermal stresses. [35] To test the validity  
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Figure 4.9.  A hypothetical model of how PE5 alters the relative rates of PA 
synthesis and of PA flow into the synthesis of other lipid classes. PE5: 1) promotes PA 
synthesis from FFA in the ER; 2) decreases the rate of PA flow into the synthesis of TAG 
in the ER; 3) decreases the rate of PA flow into the synthesis of PE in mitochondria; 4) 
decreases the rate of PA flow into the synthesis of PC and PI in the ER; and 5) increases 
the rate of PA flow into the synthesis of CL in mitochondria 
 
of this hypothesis, it is necessary to examine how genetic manipulations (such as single-
gene-deletions and elevated gene expression) that decrease or increase the concentration 
of PE, PC and PI affect stress resistance and the efficiency with which PE5 delays aging.  
Third, one of the outcomes of the observed re-wiring of lipid metabolism and 
transport in yeast cells treated with PE5 may be a decrease in the cellular concentrations 
of FFA, a class of lipids whose incorporation into PA initiates all three major routes of 
lipid metabolism in the ER, mitochondria and LDs (Figure 4.9). FFA are known to 
trigger an age-related form of programmed cell death called liponecrosis. [36, 37]  To 
validate this hypothesis, the concentrations of FFA in yeast cells treated with PE5 need to 
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be compared to those in cells that remained untreated. Furthermore, it needs to be 
examined how genetic manipulations (such as single-gene-deletions and amplified gene 
expression) that decrease or increase the concentrations of FFA in yeast cells impact the 
efficiency of liponecrosis and the ability of PE5 to delay aging.  
   Future studies also need to use quantitative mass spectrometry to monitor an 
age-related chronology of changes in various lipid classes extracted from three different 
types of purified organelles (such as the ER, mitochondria and LDs). These studies will 
allow a critical validation of my hypothesis on how PE5 alters the relative rates of PA 





5 An aging-delaying plant extract PE6 remodels cellular lipidome of 
chronologically aging yeast  
 
5.1 Abstract 
Among the aging-delaying plant extract discovered by the Titorenko laboratory is PE6. 
Recent unpublished studies in the Titorenko laboratory suggest that some aspects of lipid 
metabolism and interorganellar transport may play essential roles in the delay of aging by 
PE6. In studies described in this chapter of my Thesis, I have used mass-spectrometric 
quantitative analysis to compare the concentrations of different classes of lipids in cells 
of chronologically aging yeast exposed to PE6 or remained untreated. My findings 
indicate that PE6 alters the relative rates of phosphatidic acid (PA) formation and of PA 
flow into the synthesis of other lipids as follows: 1) it promotes PA synthesis from free 
fatty acids (FFA) in the endoplasmic reticulum (ER) late in life of chronologically aging 
yeast; 2) it decreases the rate of PA flow into the synthesis of triacylglycerols (TAG) in 
the ER late in life of chronologically aging yeast; 3) it increases the rates of PA flow into 
the synthesis of phosphatidylserine (PS), phosphatidylcholine (PC) and 
phosphatidylinositol (PI) in the ER; 4) it decreases the rates of PA flow into the synthesis 
of phosphatidylethanolamine (PE) in mitochondria; and 5) it increases the rate of PA 
flow into the synthesis of cardiolipin (CL) in mitochondria. Such re-wiring of PA 
synthesis and its conversion into TAG, PS, PC, PI, PE and CL delays aging by a 
mechanism that remains to be established. 
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5.2 Materials and Methods 
 
Yeast strains, media and growth conditions 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATD his3'1 leu2'0 lys2'0 
ura3'0) from Thermo Scientific/Open Biosystems was grown in a synthetic minimal 
YNB medium (0.67% Yeast Nitrogen Base without amino acids) initially containing 2% 
glucose and supplemented with 20 mg/l histidine, 30 mg/l leucine, 30 mg/l lysine and 20 
mg/l uracil. Cells were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer 
IODVNVDWD³IODVNYROXPHPHGLXPYROXPH´UDWLRRIThe stock solution of aging-
delaying plant extract 6 (PE6) in ethanol was made on the day of adding this PE to cell 
cultures. This stock solution was added to growth medium immediately following cell 
inoculation into the medium. The final concentration of PE6 in growth medium was 
1.0%. 
 
Lipid extraction, identification and quantitation using mass spectrometry 




VBA. All data are presented as mean ± SEM. The p values were calculated with the help 





Lipid metabolism and interorganellar transport in mitochondria, the endoplasmic 
reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. cerevisiae involve 
numerous steps, each catalyzed by a known enzyme or several enzymes (Figure 5.1).  
 
5.3.1 PE6 decreases the concentration of triacylglycerol (TAG) late in life of 
chronologically aging yeast  
Using mass-spectrometric quantitative analysis, I compared the concentrations of 
different classes of lipids in cells of chronologically aging yeast exposed to PE6 or 
remained untreated. I found that PE6 decreases the concentration of the neutral lipid TAG 
late in life of chronologically aging yeast (Figure 5.2).  
 
Figure 5.1. Lipid metabolism and interorganellar transport in mitochondria, the 
endoplasmic reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. 




Figure 5.2. PE6 decreases the concentration of the neutral lipid triacylglycerol 
(TAG) late in life of chronologically aging yeast. The wild-type strain of yeast was 
cultured in the nutrient-rich YP medium initially containing 2% glucose with or without 
PE6. Cells were recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of 
cellular lipids, as well as their mass spectrometric identification and quantitation, were 
carried out as described in Materials and Methods of chapter 2. Based on these data, the 
concentrations of TAG were calculated in mol%. Data are presented as means ± SEM (n 
= 2). 
 
5.3.2 PE6 causes an increase in the concentration of phosphatidic acid (PA) late in 
life of chronologically aging yeast 
I found that PE6 increases the concentration of PA late in life of chronologically 
aging yeast (Figure 5.3).  
 
5.3.3 PE6 increases the concentration of phosphatidylserine (PS) in 
chronologically aging yeast 
I found that PE6 causes a rise in the concentration of PS in chronologically aging 
yeast (Figure 5.4).  
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Figure 5.3. PE6 increases the concentration of phosphatidic acid (PA) late in life of 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE6. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PA were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
 
Figure 5.4. PE6 increases the concentration of phosphatidylserine (PS) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE6. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PS were calculated in mol%. Data are presented as means ± SEM (n = 2). 
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5.3.4 PE6 decreases the concentration of phosphatidylethanolamine (PE) in 
chronologically aging yeast 
I found that PE6 causes a decrease of the concentration of PE in chronologically 
aging yeast (Figure 5.5).  
 
Figure 5.5. PE6 decreases the concentration of phosphatidylethanolamine (PE) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE6. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PE were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
5.3.5 PE6 increases the concentration of phosphatidylcholine (PC) in 
chronologically aging yeast 
I found that PE6 causes a rise in the concentration of PC in chronologically aging 
yeast (Figure 5.6).  
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Figure 5.6. PE6 increases the concentration of phosphatidylcholine (PC) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE6. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PC were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
5.3.6 PE6 elevates the concentration of phosphatidylinositol (PI) in chronologically 
aging yeast 
I found that PE6 increases the concentration of PI in chronologically aging yeast 
(Figure 5.7).  
 
5.3.7 PE6 increases the concentration of cardiolipin (CL) in chronologically aging 
yeast 
I found that PE6 causes a rise in the concentration of CL (a signature lipid of the 
inner mitochondrial membrane) in chronologically aging yeast (Figure 5.8).  
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Figure 5.7. PE6 increases the concentration of phosphatidylinositol (PI) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE6. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PI were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
 
Figure 5.8. PE6 increases the concentration of cardiolipin (CL) in chronologically 
aging yeast. The wild-type strain of yeast was cultured in the nutrient-rich YP medium 
initially containing 2% glucose with or without PE6. Cells were recovered on days 1, 2, 
3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as well as their mass 
spectrometric identification and quantitation, were carried out as described in Materials 
and Methods of chapter 2. Based on these data, the concentrations of CL were calculated 
in mol%. Data are presented as means ± SEM (n = 2). 
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5.4 Discussion 
My data on how PE6 influences the concentrations of different lipid classes in 
cells of chronologically aging yeast suggest that this aging-delaying plant extract alters 
the relative rates of phosphatidic acid (PA) formation and of PA flow into the synthesis 
of other lipids as follows: 1) it promotes PA synthesis from FFA in the ER late in life of 
chronologically aging yeast; 2) it decreases the rate of PA flow into the synthesis of TAG 
in the ER late in life of chronologically aging yeast; 3) it decreases the rate of PA flow 
into the synthesis of PE in mitochondria; 4) it increases the rate of PA flow into the 
synthesis of PS, PC and PI in the ER; and 5) it increases the rate of PA flow into the 
synthesis of CL in mitochondria (Figure 5.9). Such re-wiring of PA synthesis and its 
conversion into TAG, PS, PE, PC, PI and CL delays aging by a mechanism that remains 
to be established. I speculate that this mechanism may affect several longevity-defining 
processes in chronologically aging yeast, as described below.  
First, the observed increase in the concentration of CL in mitochondria of yeast 
cells treated with PE6 may cause certain changes in the age-related chronology of 
mitochondrial functionality seen in these cells. [35] These changes involve alterations in 
mitochondrial respiration, mitochondrial membrane potential, mitochondrially produced 
ROS and stability of mitochondrial DNA. [35] To validate this hypothesis, it needs to be 
assessed how genetic manipulations (such as single-gene-deletions and amplified gene 
expression) that decrease or increase the concentration of CL in the mitochondrial 







Figure 5.9.  A hypothetical model of how PE6 alters the relative rates of PA 
synthesis and of PA flow into the synthesis of other lipid classes. PE6: 1) promotes PA 
synthesis from FFA in the ER late in life of chronologically aging yeast; 2) decreases the 
rate of PA flow into the synthesis of TAG in the ER late in life of chronologically aging 
yeast; 3) decreases the rate of PA flow into the synthesis of PE in mitochondria; 4) 
increases the rate of PA flow into the synthesis of PS, PC and PI in the ER; and 5) 
increases the rate of PA flow into the synthesis of CL in mitochondria 
 
Second, the observed increase in the concentrations of three glycerol 
phospholipids, PS, PC and PI, in yeast cells treated with PE6 may cause the increased 
resistance of these cells to chronic oxidative and thermal stresses. [35] To test the validity  
of this hypothesis, it is necessary to examine how genetic manipulations (such as single-
gene-deletions and elevated gene expression) that decrease or increase the concentration 
of PS, PC and PI affect stress resistance and the efficiency with which PE6 delays aging.  
Third, one of the outcomes of the observed re-wiring of lipid metabolism and 
transport in yeast cells treated with PE6 may be a late-life decrease in the cellular 
concentrations of FFA, a class of lipids whose incorporation into PA initiates all three 
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major routes of lipid metabolism in the ER, mitochondria and LDs (Figure 5.9). FFA are 
known to trigger an age-related form of programmed cell death called liponecrosis. [36, 
37]  To validate this hypothesis, the concentrations of FFA in yeast cells treated with PE6 
need to be compared to those in cells that remained untreated. Furthermore, it needs to be 
examined how genetic manipulations (such as single-gene-deletions and amplified gene 
expression) that decrease or increase the concentrations of FFA in yeast cells impact the 
efficiency of liponecrosis and the ability of PE6 to delay aging.  
   Future studies also need to use quantitative mass spectrometry to monitor an 
age-related chronology of changes in various lipid classes extracted from three different 
types of purified organelles (such as the ER, mitochondria and LDs). These studies will 
allow a critical validation of my hypothesis on how PE6 alters the relative rates of PA 





6 An aging-delaying plant extract PE8 remodels cellular lipidome of 
chronologically aging yeast  
 
6.1 Abstract 
Among the aging-delaying plant extract discovered by the Titorenko laboratory is PE8. 
Recent unpublished studies in the Titorenko laboratory suggest that some aspects of lipid 
metabolism and interorganellar transport may play essential roles in the delay of aging by 
PE8. In studies described in this chapter of my Thesis, I have used mass-spectrometric 
quantitative analysis to compare the concentrations of different classes of lipids in cells 
of chronologically aging yeast exposed to PE8 or remained untreated. My findings 
indicate that PE8 alters the relative rates of PA flow into the synthesis of other lipids as 
follows: 1) it decreases the rate of PA flow into the synthesis of triacylglycerols (TAG) in 
the ER; 2) it increases the rate of PA flow into the synthesis of phosphatidylethanolamine 
(PE) in mitochondria; 3) it decreases the rates of PA flow into the synthesis of 
phosphatidylserine (PS) and phosphatidylcholine (PC) in the ER early in life of 
chronologically aging yeast; 4) it increases the rate of PA flow into the synthesis of 
phosphatidylinositol (PI) in the ER; and 5) it decreases the rate of PA flow into the 
synthesis of cardiolipin (CL) in mitochondria early in life of chronologically aging yeast. 
Such re-wiring of PA conversion into TAG, PS, PC, PI, PE and CL delays aging by a 
mechanism that remains to be established. 




6.2 Materials and Methods 
 
Yeast strains, media and growth conditions 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATD his3'1 leu2'0 lys2'0 
ura3'0) from Thermo Scientific/Open Biosystems was grown in a synthetic minimal 
YNB medium (0.67% Yeast Nitrogen Base without amino acids) initially containing 2% 
glucose and supplemented with 20 mg/l histidine, 30 mg/l leucine, 30 mg/l lysine and 20 
mg/l uracil. Cells were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer 
IODVNVDWD³IODVNYROXPHPHGLXPYROXPH´UDWLRRIThe stock solution of aging-
delaying plant extract 8 (PE8) in ethanol was made on the day of adding this PE to cell 
cultures. This stock solution was added to growth medium immediately following cell 
inoculation into the medium. The final concentration of PE8 in growth medium was 
0.3%. 
 
Lipid extraction, identification and quantitation using mass spectrometry 




VBA. All data are presented as mean ± SEM. The p values were calculated with the help 





Lipid metabolism and interorganellar transport in mitochondria, the endoplasmic 
reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. cerevisiae involve 
numerous steps, each catalyzed by a known enzyme or several enzymes (Figure 6.1).  
 
6.3.1 PE8 decreases the concentration of triacylglycerol (TAG) in chronologically 
aging yeast  
Using mass-spectrometric quantitative analysis, I compared the concentrations of 
different classes of lipids in cells of chronologically aging yeast exposed to PE8 or 
remained untreated. I found that PE8 decreases the concentration of the neutral lipid TAG 
in chronologically aging yeast (Figure 6.2).  
 
Figure 6.1. Lipid metabolism and interorganellar transport in mitochondria, the 
endoplasmic reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. 




Figure 6.2. PE8 decreases the concentration of the neutral lipid triacylglycerol 
(TAG) in chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE8. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of TAG were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
6.3.2 PE8 causes a decrease in the concentration of phosphatidic acid (PA) in 
chronologically aging yeast 
I found that PE8 decreases the concentration of PA in chronologically aging yeast 
(Figure 6.3).  
 
6.3.3 PE8 decreases the concentration of phosphatidylserine (PS) early in life of 
chronologically aging yeast 
I found that PE8 causes a decrease in the concentration of PS early in life of 
chronologically aging yeast (Figure 6.4).  
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Figure 6.3. PE8 decreases the concentration of phosphatidic acid (PA) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE8. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PA were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
 
Figure 6.4. PE8 decreases the concentration of phosphatidylserine (PS) early in life 
of chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE8. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PS were calculated in mol%. Data are presented as means ± SEM (n = 2). 
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6.3.4 PE8 increases the concentration of phosphatidylethanolamine (PE) in 
chronologically aging yeast 
I found that PE8 causes a rise of the concentration of PE in chronologically aging 
yeast (Figure 6.5).  
 
Figure 6.5. PE8 increases the concentration of phosphatidylethanolamine (PE) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE8. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PE were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
6.3.5 PE8 decreases the concentration of phosphatidylcholine (PC) early in life and 
increases it late in life of chronologically aging yeast 
I found that PE8 causes a decrease in the concentration of PC early in life and 
increases it late in life of chronologically aging yeast (Figure 6.6).  
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Figure 6.6. PE8 decreases the concentration of phosphatidylcholine (PC) early in life 
and increases it late in life of chronologically aging yeast. The wild-type strain of yeast 
was cultured in the nutrient-rich YP medium initially containing 2% glucose with or 
without PE8. Cells were recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction 
of cellular lipids, as well as their mass spectrometric identification and quantitation, were 
carried out as described in Materials and Methods of chapter 2. Based on these data, the 
concentrations of PC were calculated in mol%. Data are presented as means ± SEM (n = 
2). 
 
6.3.6 PE8 elevates the concentration of phosphatidylinositol (PI) in chronologically 
aging yeast 
I found that PE8 increases the concentration of PI in chronologically aging yeast 
(Figure 6.7).  
 
6.3.7 PE8 decreases the concentration of cardiolipin (CL) early in life of 
chronologically aging yeast 
I found that PE8 causes a decrease in the concentration of CL early in life of 
chronologically aging yeast (Figure 6.8).  
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Figure 6.7. PE8 increases the concentration of phosphatidylinositol (PI) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE8. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PI were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
 
Figure 6.8. PE8 decreases the concentration of cardiolipin (CL) early in life of 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE8. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of CL were calculated in mol%. Data are presented as means ± SEM (n = 2). 
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6.4 Discussion 
My data on how PE8 influences the concentrations of different lipid classes in 
cells of chronologically aging yeast suggest that this aging-delaying plant extract alters 
the relative rates of phosphatidic acid (PA) flow into the synthesis of other lipids as 
follows: 1) it decreases the rate of PA flow into the synthesis of TAG in the ER; 2) it 
increases the rate of PA flow into the synthesis of PE in mitochondria; 3) it decreases the 
rates of PA flow into the synthesis of PS and PC in the ER early in life of chronologically 
aging yeast; 4) it increases the rate of PA flow into the synthesis PI in the ER; and 5) it 
decreases the rate of PA flow into the synthesis of CL in mitochondria early in life of 
chronologically aging yeast (Figure 6.9). Such re-wiring of PA conversion into TAG, PS, 
PE, PC, PI and CL delays aging by a mechanism that remains to be established. I 
speculate that this mechanism may affect several longevity-defining processes in 
chronologically aging yeast, as described below.  
First, the observed decrease in the concentration of CL in mitochondria of yeast 
cells treated with PE8 may cause certain changes in the age-related chronology of 
mitochondrial functionality seen in these cells. [35] These changes involve alterations in 
mitochondrial respiration, mitochondrial membrane potential, mitochondrially produced 
ROS and stability of mitochondrial DNA. [35] To validate this hypothesis, it needs to be 
assessed how genetic manipulations (such as single-gene-deletions and amplified gene 
expression) that decrease or increase the concentration of CL in the mitochondrial 







Figure 6.9.  A hypothetical model of how PE8 alters the relative rates of PA 
synthesis and of PA flow into the synthesis of other lipid classes. PE8: 1) decreases the 
rate of PA flow into the synthesis of TAG in the ER; 2) increases the rate of PA flow into 
the synthesis of PE in mitochondria; 3) decreases the rates of PA flow into the synthesis 
of PS and PC in the ER early in life of chronologically aging yeast; 4) increases the rate 
of PA flow into the synthesis PI in the ER; and 5) decreases the rate of PA flow into the 
synthesis of CL in mitochondria early in life of chronologically aging yeast. 
 
Second, the observed changes in the concentrations of four glycerol 
phospholipids, PS, PE, PC and PI, in yeast cells treated with PE8 may cause the increased 
resistance of these cells to chronic oxidative and thermal stresses. [35] To test the validity  
of this hypothesis, it is necessary to examine how genetic manipulations (such as single-
gene-deletions and elevated gene expression) that decrease or increase the concentration 
of PS, PE, PC and PI affect stress resistance and the efficiency with which PE8 delays 
aging.  
Third, one of the outcomes of the observed re-wiring of lipid metabolism and 
transport in yeast cells treated with PE8 may be a late-life decrease in the cellular 
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concentrations of FFA, a class of lipids whose incorporation into PA initiates all three 
major routes of lipid metabolism in the ER, mitochondria and LDs (Figure 6.9). FFA are 
known to trigger an age-related form of programmed cell death called liponecrosis. [36, 
37]  To validate this hypothesis, the concentrations of FFA in yeast cells treated with PE8 
need to be compared to those in cells that remained untreated. Furthermore, it needs to be 
examined how genetic manipulations (such as single-gene-deletions and amplified gene 
expression) that decrease or increase the concentrations of FFA in yeast cells impact the 
efficiency of liponecrosis and the ability of PE8 to delay aging.  
   Future studies also need to use quantitative mass spectrometry to monitor an 
age-related chronology of changes in various lipid classes extracted from three different 
types of purified organelles (such as the ER, mitochondria and LDs). These studies will 
allow a critical validation of my hypothesis on how PE8 alters the relative rates of PA 





7 An aging-delaying plant extract PE12 remodels cellular lipidome of 
chronologically aging yeast  
 
7.1 Abstract 
Among the aging-delaying plant extract discovered by the Titorenko laboratory is PE12. 
Recent unpublished studies in the Titorenko laboratory suggest that some aspects of lipid 
metabolism and interorganellar transport may play essential roles in the delay of aging by 
PE12. In studies described in this chapter of my Thesis, I have used mass-spectrometric 
quantitative analysis to compare the concentrations of different classes of lipids in cells 
of chronologically aging yeast exposed to PE12 or remained untreated. My findings 
indicate that PE12 alters the relative rates of PA flow into the synthesis of other lipids as 
follows: 1) it decreases the rate of PA flow into the synthesis of triacylglycerols (TAG) in 
the ER; 2) it increases the rate of PA flow into the synthesis of phosphatidylethanolamine 
(PE) in mitochondria; 3) it increases the rate of PA flow into the synthesis of 
phosphatidylserine (PS) in the ER early in life of chronologically aging yeast; 4) it 
increases the rate of PA flow into the synthesis of phosphatidylcholine (PC) and 
phosphatidylinositol (PI) in the ER late in life of chronologically aging yeast; and 5) it 
decreases the rate of PA flow into the synthesis of cardiolipin (CL) in mitochondria early 
in life of chronologically aging yeast. Such re-wiring of PA conversion into TAG, PS, 
PC, PI, PE and CL delays aging by a mechanism that remains to be established. 




7.2 Materials and Methods 
 
Yeast strains, media and growth conditions 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATD his3'1 leu2'0 lys2'0 
ura3'0) from Thermo Scientific/Open Biosystems was grown in a synthetic minimal 
YNB medium (0.67% Yeast Nitrogen Base without amino acids) initially containing 2% 
glucose and supplemented with 20 mg/l histidine, 30 mg/l leucine, 30 mg/l lysine and 20 
mg/l uracil. Cells were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer 
IODVNVDWD³IODVNYROXPHPHGLXPYROXPH´UDWLRRIThe stock solution of aging-
delaying plant extract 12 (PE12) in ethanol was made on the day of adding this PE to cell 
cultures. This stock solution was added to growth medium immediately following cell 
inoculation into the medium. The final concentration of PE12 in growth medium was 
0.1%. 
 
Lipid extraction, identification and quantitation using mass spectrometry 




VBA. All data are presented as mean ± SEM. The p values were calculated with the help 





Lipid metabolism and interorganellar transport in mitochondria, the endoplasmic 
reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. cerevisiae involve 
numerous steps, each catalyzed by a known enzyme or several enzymes (Figure 7.1).  
 
7.3.1 PE12 decreases the concentration of triacylglycerol (TAG) in chronologically 
aging yeast  
Using mass-spectrometric quantitative analysis, I compared the concentrations of 
different classes of lipids in cells of chronologically aging yeast exposed to PE12 or 
remained untreated. I found that PE12 decreases the concentration of the neutral lipid 
TAG in chronologically aging yeast (Figure 7.2).  
 
Figure 7.1. Lipid metabolism and interorganellar transport in mitochondria, the 
endoplasmic reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. 




Figure 7.2. PE12 decreases the concentration of the neutral lipid triacylglycerol 
(TAG) in chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE12. Cells 
were recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, 
as well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of TAG were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
7.3.2 PE12 causes a decrease in the concentration of phosphatidic acid (PA) early 
in life of chronologically aging yeast 
I found that PE12 decreases the concentration of PA early in life of 
chronologically aging yeast (Figure 7.3).  
 
7.3.3 PE12 increases the concentration of phosphatidylserine (PS) early in life of 
chronologically aging yeast 
I found that PE12 causes a rise in the concentration of PS early in life of 
chronologically aging yeast (Figure 7.4).  
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Figure 7.3. PE12 decreases the concentration of phosphatidic acid (PA) early in life 
of chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE12. Cells 
were recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, 
as well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PA were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
 
Figure 7.4. PE12 increases the concentration of phosphatidylserine (PS) early in life 
of chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE12. Cells 
were recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, 
as well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PS were calculated in mol%. Data are presented as means ± SEM (n = 2). 
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7.3.4 PE12 increases the concentration of phosphatidylethanolamine (PE) in 
chronologically aging yeast 
I found that PE12 causes a rise of the concentration of PE in chronologically 
aging yeast (Figure 7.5).  
 
Figure 7.5. PE12 increases the concentration of phosphatidylethanolamine (PE) in 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE12. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PE were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
7.3.5 PE12 increases the concentration of phosphatidylcholine (PC) late in life of 
chronologically aging yeast 
I found that PE12 causes a rise in the concentration of PC late in life of 
chronologically aging yeast (Figure 7.6).  
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Figure 7.6. PE12 increases the concentration of phosphatidylcholine (PC) late in life 
of chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE12. Cells 
were recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, 
as well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of PC were calculated in mol%. Data are presented as means ± SEM (n = 2). 
 
7.3.6 PE12 elevates the concentration of phosphatidylinositol (PI) late in life of 
chronologically aging yeast 
I found that PE12 increases the concentration of PI late in life of chronologically 
aging yeast (Figure 7.7).  
 
7.3.7 PE12 decreases the concentration of cardiolipin (CL) early in life of 
chronologically aging yeast 
I found that PE12 causes a decrease in the concentration of CL early in life of 




Figure 7.7. PE12 increases the concentration of phosphatidylinositol (PI) late in life 
of chronologically aging yeast. The wild-type strain of yeast was cultured in the 
nutrient-rich YP medium initially containing 2% glucose with or without PE12. Cells 
were recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, 
as well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 




Figure 7.8. PE12 decreases the concentration of cardiolipin (CL) early in life of 
chronologically aging yeast. The wild-type strain of yeast was cultured in the nutrient-
rich YP medium initially containing 2% glucose with or without PE12. Cells were 
recovered on days 1, 2, 3, 4, 5, 6, 8 or 10 of culturing. Extraction of cellular lipids, as 
well as their mass spectrometric identification and quantitation, were carried out as 
described in Materials and Methods of chapter 2. Based on these data, the concentrations 
of CL were calculated in mol%. Data are presented as means ± SEM (n = 2). 
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7.4 Discussion 
My data on how PE12 influences the concentrations of different lipid classes in cells of 
chronologically aging yeast suggest that this aging-delaying plant extract alters the 
relative rates of phosphatidic acid (PA) flow into the synthesis of other lipids as follows: 
1) it decreases the rate of PA flow into the synthesis of triacylglycerols (TAG) in the ER; 
2) it increases the rate of PA flow into the synthesis of phosphatidylethanolamine (PE) in 
mitochondria; 3) it increases the rate of PA flow into the synthesis of phosphatidylserine 
(PS) in the ER early in life of chronologically aging yeast; 4) it increases the rate of PA 
flow into the synthesis of phosphatidylcholine (PC) and phosphatidylinositol (PI) in the 
ER late in life of chronologically aging yeast; and 5) it decreases the rate of PA flow into 
the synthesis of cardiolipin (CL) in mitochondria early in life of chronologically aging 
yeast (Figure 7.9). Such re-wiring of PA conversion into TAG, PS, PC, PI, PE and CL 
delays aging by a mechanism that remains to be established. I speculate that this 
mechanism may affect several longevity-defining processes in chronologically aging 
yeast, as described below.  
First, the observed decrease in the concentration of CL in mitochondria of yeast 
cells treated with PE12 may cause certain changes in the age-related chronology of 
mitochondrial functionality seen in these cells. [35] These changes involve alterations in 
mitochondrial respiration, mitochondrial membrane potential, mitochondrially produced 
ROS and stability of mitochondrial DNA. [35] To validate this hypothesis, it needs to be 
assessed how genetic manipulations (such as single-gene-deletions and amplified gene 
expression) that decrease or increase the concentration of CL in the mitochondrial 




Figure 7.9.  A hypothetical model of how PE12 alters the relative rates of PA 
synthesis and of PA flow into the synthesis of other lipid classes. PE12: 1) decreases 
the rate of PA flow into the synthesis of TAG in the ER; 2) increases the rate of PA flow 
into the synthesis of PE in mitochondria; 3) increases the rate of PA flow into the 
synthesis of PS in the ER early in life of chronologically aging yeast; 4) increases the rate 
of PA flow into the synthesis of PC and PI in the ER late in life of chronologically aging 
yeast; and 5) decreases the rate of PA flow into the synthesis of CL in mitochondria early 
in life of chronologically aging yeast  
 
Second, the observed changes in the concentrations of four glycerol 
phospholipids, PS, PE, PC and PI, in yeast cells treated with PE12 may cause the 
increased resistance of these cells to chronic oxidative and thermal stresses. [35] To test 
the validity of this hypothesis, it is necessary to examine how genetic manipulations 
(such as single-gene-deletions and elevated gene expression) that decrease or increase the 
concentration of PS, PE, PC and PI affect stress resistance and the efficiency with which 
PE12 delays aging.  
Third, one of the outcomes of the observed re-wiring of lipid metabolism and 
transport in yeast cells treated with PE12 may be a late-life decrease in the cellular 
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concentrations of FFA, a class of lipids whose incorporation into PA initiates all three 
major routes of lipid metabolism in the ER, mitochondria and LDs (Figure 7.9). FFA are 
known to trigger an age-related form of programmed cell death called liponecrosis. [36, 
37]  To validate this hypothesis, the concentrations of FFA in yeast cells treated with PE8 
need to be compared to those in cells that remained untreated. Furthermore, it needs to be 
examined how genetic manipulations (such as single-gene-deletions and amplified gene 
expression) that decrease or increase the concentrations of FFA in yeast cells impact the 
efficiency of liponecrosis and the ability of PE12 to delay aging.  
   Future studies also need to use quantitative mass spectrometry to monitor an 
age-related chronology of changes in various lipid classes extracted from three different 
types of purified organelles (such as the ER, mitochondria and LDs). These studies will 
allow a critical validation of my hypothesis on how PE12 alters the relative rates of PA 





8 General Discussion 
My findings imply that each of the 6 aging-delaying plant extracts causes age-
related changes in cellular lipidomes of chronologically aging yeast. I demonstrated that 
each of these extracts differently alters the relative rates of PA formation and PA flow 
into the biosynthetic pathways for TAG in the ER, glycerol phospholipids in the ER and 
mitochondria, and CL in mitochondria. The summary of changes in the concentrations of 
various lipid classes in yeast cells treated with different aging-delaying plant extracts is 
presented in Table 8.1. Three consecutive stages of the chronological aging process can 
be distinguished with regard to such changes. They include the early-age (days 1-2 of 
culturing), intermediate-age (days 3-4 of culturing) and late-age (days 5-10 of culturing) 
stages.  
The only common feature of age-related changes in the cellular lipidomes of yeast 
treated with each of the 6 aging-delaying plant extracts is a decrease in the concentration 
of TAG. In yeast treated with PE4, PE5, PE8, PE12 or PE21, such decrease occurs during 
each of the three stages of the chronological aging process (Table 8.1). In yeast treated 
with PE6, the decrease in the concentration of cellular TAG can be seen only during the 
late-age (days 5-10 of culturing) stage (Table 8.1). 
Different aging-delaying plant extracts differently impact the concentration of PA. 
PE21 does not alter PA concentration at any of the stages of the chronological aging 
process (Table 8.1), PE4 and PE5 increase it during each of the three stages (Table 8.1), 
PE8 decrease PA concentration during each of the three stages (Table 8.1), PE6 increases 
PA concentration only during the late-age (days 5-10) stage (Table 8.1), whereas PE12 
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decreases PA concentration during the early-age (days 1-2) and intermediate-age (days 3-
4) stages (Table 8.1). 
 
Table 8.1. Summary of changes in the concentrations of various lipid classes in yeast 
cells treated with different aging-delaying plant extracts at the early-age (days 1-2), 




 Days 1-2  Days 3-4 Days 5-10 
TAG ª ª ª 
PA NS NS NS 
PS NS © © 
PE © © © 
PC NS NS © 
PI NS NS © 
CL ª ª ª 
 
0.5% PE4: 
 Days 1-2  Days 3-4 Days 5-10 
TAG ª ª ª 
PA © © © 
PS NS NS NS 
PE NS © © 
PC NS NS NS 
PI © © © 
CL © © © 
 
0.5% PE5: 
 Days 1-2  Days 3-4 Days 5-10 
TAG ª ª ª 
PA © © © 
PS NS NS NS 
PE ª ª ª 
PC ª ª ª 
PI ª ª ª 
CL © © © 
 
1.0% PE6: 
 Days 1-2  Days 3-4 Days 5-10 
TAG NS NS ª 
PA NS NS © 
PS © © © 
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PE ª ª ª 
PC © © © 
PI © © © 
CL © © © 
 
0.3% PE8: 
 Days 1-2  Days 3-4 Days 5-10 
TAG ª ª ª 
PA ª ª ª 
PS ª NS NS 
PE © © © 
PC ª NS © 
PI © © © 
CL ª ª NS 
 
0.1% PE12: 
 Days 1-2  Days 3-4 Days 5-10 
TAG ª ª ª 
PA ª ª NS 
PS © NS NS 
PE © © © 
PC NS © © 
PI NS © © 
CL ª ª NS 
 
Different aging-delaying plant extracts differently impact the concentrations of 
glycerol phospholipids that are synthesized in the ER (i.e. PS, PC and PI) or in 
mitochondria (i.e. PE and CL) (Table 8.1). 
My findings for the first time demonstrate that different aging-delaying 
pharmacological interventions can cause different types of a re-wiring of lipid 
metabolism and transport in yeast cells. It remains to be seen how important is each of 
these different types of changes in lipid dynamics for the ability of each of the 6 plant 
extracts to delay yeast chronological aging. Moreover, mechanisms through which such 
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